Positions

Selected Publications

Academic Article

Year Title Altmetric
2023 Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study.Journal of Neurology2023
2023 Primary results of a phase-III, randomized controlled trial of the Behavioral Intervention for increasing Physical Activity in Multiple Sclerosis project 2023
2023 Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosisJournal of Neurology.  270:1543-1563. 2023
2023 Exploratory clinical efficacy and patient-reported outcomes from NOVA: a randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosisMultiple Sclerosis and Related Disorders.  104561. 2023
2023 Randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis project: Secondary, patient-reported outcomesContemporary Clinical Trials.  125. 2023
2023 Attitudes of people with multiple sclerosis toward brain donationFrontiers in Neurology.  14. 2023
2023 Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis 2023
2023 Diet, Physical Activity, and Stress Among Wheelchair Users With Multiple Sclerosis: Examining Individual and Co-Occurring Behavioral Risk FactorsArchives of Physical Medicine and Rehabilitation2023
2023 Impact of the COVID-19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registryMuscle and Nerve.  67:25-32. 2023
2023 The best and worst of times in therapy development for myasthenia gravisMuscle and Nerve.  67:12-16. 2023
2023 The nine hole peg test as an outcome measure in progressive MS trialsMultiple Sclerosis and Related Disorders.  69. 2023
2022 Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy 2022
2022 Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpointAlzheimer's and Dementia.  18. 2022
2022 Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trialEBioMedicine.  86. 2022
2022 Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumoniaAntimicrobial Resistance and Infection Control.  11. 2022
2022 Diet, Physical Activity, and Stress Among Wheelchair Users with Multiple Sclerosis: Examining Behavioral Risk FactorsArchives of Physical Medicine and Rehabilitation.  103:e180-e181. 2022
2022 SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distributionBMC Nephrology.  23. 2022
2022 The emerging postural instability phenotype in idiopathic Parkinson diseasenpj Parkinson's Disease.  8. 2022
2022 The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx studyJournal of Neurology.  269:6202-6210. 2022
2022 Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialAmerican Journal of the Medical Sciences.  364:538-546. 2022
2022 Treatment for Mild Chronic Hypertension During PregnancyObstetrical and Gynecological Survey.  77:634-636. 2022
2022 Advocating for in-center hemodialysis patients via anonymous surveyMedicine.  101:E30937. 2022
2022 Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple SclerosisNeurology.  99:E1538-E1548. 2022
2022 Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function: Safety of Lactated Ringer's in kidney diseaseAmerican Journal of the Medical Sciences.  364:433-443. 2022
2022 One-year follow-up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient RegistryMuscle and Nerve.  66:411-420. 2022
2022 T55. POLYGENICITY OF COMORBID DEPRESSION IN MULTIPLE SCLEROSISEuropean Neuropsychopharmacology.  63:e198. 2022
2022 Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosisJournal of Neurology.  269:5531-5540. 2022
2022 The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis 2022
2022 The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial datasetJournal of Neurology.  269:5319-5327. 2022
2022 136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MSJournal of Neurology, Neurosurgery and Psychiatry.  93:e2.91. 2022
2022 COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomesMultiple Sclerosis and Related Disorders.  65. 2022
2022 The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials 2022
2022 Ublituximab versus Teriflunomide in Relapsing Multiple SclerosisNew England Journal of Medicine.  387:704-714. 2022
2022 Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple SclerosisNeurology: Clinical Practice.  12:E58-E65. 2022
2022 Treatment for Mild Chronic Hypertension During PregnancyObstetrical and Gynecological Survey.  77:460-462. 2022
2022 Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissions 2022
2022 Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialLancet Neurology.  21:608-619. 2022
2022 Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseasesMultiple Sclerosis and Related Disorders.  63. 2022
2022 Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS 2022
2022 The Potential for EBV Vaccines to Prevent Multiple SclerosisFrontiers in Neurology.  13. 2022
2022 Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple SclerosisFrontiers in Neurology.  13. 2022
2022 036 Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline dataJournal of Neurology, Neurosurgery and Psychiatry.  93:a24.3-a2a25. 2022
2022 COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settingsArthritis and Rheumatology.  74:1091-1092. 2022
2022 Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study 2022
2022 Disparities in Telehealth Care in Multiple SclerosisNeurology: Clinical Practice.  12:223-233. 2022
2022 Treatment for Mild Chronic Hypertension during PregnancyNew England Journal of Medicine.  386:1781-1792. 2022
2022 Subsurface Eddy Facilitates Retention of Simulated Diel Vertical Migrators in a Biological HotspotJournal of Geophysical Research: Oceans.  127. 2022
2022 The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questionsMultiple Sclerosis and Related Disorders.  61. 2022
2022 Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosisMultiple Sclerosis Journal - Experimental, Translational and Clinical.  8. 2022
2022 Do physical activity, cardiorespiratory fitness, and subcortical brain structures explain reduced walking performance in older adults with multiple sclerosis?Multiple Sclerosis and Related Disorders.  60. 2022
2022 Early first-line treatment response and subsequent disability worsening in relapsing–remitting multiple sclerosisEuropean Journal of Neurology.  29:1106-1116. 2022
2022 Exercise training in multiple sclerosisLancet Neurology.  21:313. 2022
2022 MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis 2022
2022 Measuring cognitive function by the SDMT across functional domains: Useful but not sufficientMultiple Sclerosis and Related Disorders.  60. 2022
2022 Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial 2022
2022 Perceptions of physical activity guidelines among wheelchair users with multiple sclerosisMultiple Sclerosis Journal - Experimental, Translational and Clinical.  8. 2022
2022 Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapiesMultiple Sclerosis and Related Disorders.  60. 2022
2022 Résultats primaires de NOVA : une étude contrôlée randomisée comparant l’administration de natalizumab toutes les 6 semaines versus une administration continue toutes les 4 semaines dans le traitement de la sclérose en plaquesRevue Neurologique.  178:s119-s120. 2022
2022 Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple SclerosisNeurology: Clinical Practice.  12:102-112. 2022
2022 The Non-Inferiority Complex: What Do Non-Inferiority Trials Tell Us?Journal of the American Society of Nephrology.  33:674-676. 2022
2022 The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experienceJournal of Neurology.  269:1758-1763. 2022
2022 A Systematic Method to Explore Radio-Frequency Non-Thermal Effect on the Growth of Saccharomyces CerevisiaeIEEE Journal of Electromagnetics Rf and Microwaves in Medicine and Biology.  6:52-60. 2022
2022 Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trialsEuropean Journal of Neurology.  29:843-854. 2022
2022 Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple SclerosisMultiple Sclerosis and Related Disorders.  59:103626. 2022
2022 Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial datasetJournal of Neurology.  269:1663-1669. 2022
2022 Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trialEuropean Journal of Neurology.  29:515-521. 2022
2022 Mendelian randomization in the multivariate general linear model frameworkGenetic Epidemiology.  46:17-31. 2022
2022 The timed 25-foot walk in a large cohort of multiple sclerosis patients 2022
2022 Video Telehealth Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Is Associated with Clinical Improvement Similar to Center-based Pulmonary RehabilitationAnnals of the American Thoracic Society.  19:332-335. 2022
2022 Multiple Sclerosis Diagnostic Criteria: Moving Ahead or Walking in Place?Neurology.  98:12-13. 2022
2022 AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorderMultiple Sclerosis and Related Disorders.  57. 2022
2022 Effects of exercise on sleep spindles in Parkinson's disease.Frontiers in Rehabilitation Sciences.  3:952289. 2022
2022 Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's DiseaseJournal of Alzheimer's Disease.  87:489-501. 2022
2022 Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS 2022
2022 Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease 2022
2022 Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal of Parkinson's Disease.  12:557-570. 2022
2022 The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives.Journal of Central Nervous System Disease.  14:11795735221123911. 2022
2022 White matter tracts that overlap with the thalamus and the putamen are protected against multiple sclerosis pathologyMultiple Sclerosis and Related Disorders.  57. 2022
2021 Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple SclerosisFrontiers in Neurology.  12. 2021
2021 Accuracy and Repeatability of Internet-ordered Spectacle LensesOptometry and Vision Science.  98:1340-1347. 2021
2021 Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosisEuropean Journal of Neurology.  28:4135-4145. 2021
2021 Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learningLaboratory Investigation.  101:1585-1596. 2021
2021 Diet quality assessment in wheelchair users with multiple sclerosisNutrients.  13. 2021
2021 Hydroxychloroquine for Primary Progressive Multiple SclerosisAnnals of Neurology.  90:940-948. 2021
2021 Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite StudyAnnals of Neurology.  90:874-886. 2021
2021 Arteriovenous Fistula Nonmaturation: What's the Immune System Got to Do with It? 2021
2021 A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple SclerosisInternational Journal of MS Care.  23:245-252. 2021
2021 Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl FumarateInternational Journal of MS Care.  23:239-244. 2021
2021 Effects of walking exercise training on learning and memory and hippocampal neuroimaging outcomes in MS: A targeted, pilot randomized controlled trialContemporary Clinical Trials.  110. 2021
2021 Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: A pilot two-arm trialRheumatology.  60:5002-5011. 2021
2021 NARCOMS and Other Registries in Multiple Sclerosis: Issues and InsightsInternational Journal of MS Care.  23:276-285. 2021
2021 Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD 2021
2021 Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple SclerosisNeurology.  97:E1560-E1570. 2021
2021 A comparison of clinical outcomes in PPMS in the INFORMS original trial data set 2021
2021 An enrichment strategy for clinical trials in SPMS 2021
2021 Cannabis Use for Symptom Management Among People with Multiple Sclerosis (PwMS): A 2020 NARCOMS SurveyArchives of Physical Medicine and Rehabilitation.  102:e23-e24. 2021
2021 Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis 2021
2021 Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosisMultiple Sclerosis and Related Disorders.  55. 2021
2021 If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?Neurotherapeutics.  18:2419-2420. 2021
2021 Physical activity and self-reported sleep quality in adults with multiple sclerosisDisability and Health Journal.  14. 2021
2021 Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease SpectrumNeurology.  97:e1334-e1342. 2021
2021 COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry 2021
2021 Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsyEpilepsy and Behavior.  122. 2021
2021 Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE)Muscle and Nerve.  64:270-276. 2021
2021 How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity.Neurology: Clinical Practice.  11:335-341. 2021
2021 Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled TrialArthritis and Rheumatology.  73:1523-1532. 2021
2021 The Importance and Opportunity for Healthy Aging Through Lifestyle, Behavior Medicine Among Older Adults With Multiple Sclerosis: the Case Based on Physical ActivityCurrent Treatment Options in Neurology.  23. 2021
2021 Uptake and Attitudes About Immunizations in People With Multiple Sclerosis.Neurology: Clinical Practice.  11:327-334. 2021
2021 A novel Mendelian randomization method with binary risk factor and outcomeGenetic Epidemiology.  45:549-560. 2021
2021 Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancerCancer Research.  81:1747-1747. 2021
2021 Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learningCancer Research.  81:671-671. 2021
2021 Artificial intelligence extension of the OSCAR-IB criteriaAnnals of Clinical and Translational Neurology.  8:1528-1542. 2021
2021 Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease 2021
2021 Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?European Journal of Neurology.  28:2115-2120. 2021
2021 Outcomes and Risk Factors Associated with SARS-CoV-2 Infection in a North American Registry of Patients with Multiple SclerosisJAMA Neurology.  78:699-708. 2021
2021 POS0135 REDUCING IMMUNOGENICITY OF PEGLOTICASE (RECIPE) WITH CONCOMITANT USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH REFRACTORY GOUT: A PHASE II RANDOMIZED CONTROLLED TRIALAnnals of the Rheumatic Diseases.  80:279-280. 2021
2021 Acute flaccid myelitis: Long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitisBMJ Neurology Open.  3. 2021
2021 Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility TrialNeurology.  96:e2313-e2322. 2021
2021 521 Prevalence and Impact of Restless Legs in Patients with Myasthenia GravisSleep.  44:a205-a206. 2021
2021 Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder 2021
2021 Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional studyMultiple Sclerosis and Related Disorders.  50. 2021
2021 Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder BiomarkerAnnals of Neurology.  89:895-910. 2021
2021 The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisJournal of Neurology.  268:1598-1607. 2021
2021 UAB-UCSD o'brien center for acute kidney injury research 2021
2021 Améliorations des scores SymptoMScreen rapportés par les patients atteints de sclérose en plaques récurrente-rémittente (SEP-RR) traités par ocrelizumab (OCR) : résultats à 2 ans de l’étude CASTINGRevue Neurologique.  177:s107-s108. 2021
2021 Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsyEpilepsy and Behavior.  117. 2021
2021 NF106: A neurofibromatosis clinical trials consortium phase II trial of the MEK inhibitor mirdametinib (PD-0325901) in adolescents and adults with NF1-related plexiform neurofibromasJournal of Clinical Oncology.  39:797-806. 2021
2021 Randomized trial testing an online responsible vendor training in recreational Marijuana stores in the United StatesJournal of Studies on Alcohol and Drugs.  82:204-213. 2021
2021 Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning 2021
2021 CSF plasmablasts differentiate MS from other neurologic disordersMultiple Sclerosis and Related Disorders.  48. 2021
2021 Treatment Response Score to Glatiramer Acetate or Interferon Beta-1aNeurology.  96:e214-e227. 2021
2021 Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple SclerosisNeurology.  96:E111-E120. 2021
2021 A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimodTherapeutic Advances in Neurological Disorders.  14. 2021
2021 Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trialNature Medicine.  27:165-173. 2021
2021 Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trialNeuroImage: Clinical.  32. 2021
2021 Disease-modifying therapy prescription patterns in people with multiple sclerosis by ageTherapeutic Advances in Neurological Disorders.  14. 2021
2021 New applications for independent activities of daily living in measuring disability in multiple sclerosis 2021
2021 Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients With Parkinson's Disease and a GBA Mutation: Results From Part 1 of the Randomised, Double-Blinded, Placebo-Controlled MOVES-PD Trial 2021
2021 Slow Wave Sleep and EEG Delta Spectral Power are Associated with Cognitive Function in Parkinson's DiseaseJournal of Parkinson's Disease.  11:703-714. 2021
2021 The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing-Remitting Multiple sclerosis: A CombiRx Secondary Analysis.Journal of Central Nervous System Disease.  13:11795735211042173. 2021
2020 NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDYNeuro-Oncology.  22:iii419-iii419. 2020
2020 Anticholinergic burden among participants in Alzheimer’s clinical trialsAlzheimer's and Dementia.  16. 2020
2020 COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)Lancet Neurology.  19:970-971. 2020
2020 Comorbidity burden in Alzheimer’s disease clinical trialsAlzheimer's and Dementia.  16. 2020
2020 Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis ComplexPediatric Neurology.  113:46-50. 2020
2020 Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Neurology.  19:988-997. 2020
2020 CTNI-10. MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104)Neuro-Oncology.  22:ii43-ii43. 2020
2020 A longitudinal study of symptom botheration in Multiple Sclerosis.Multiple Sclerosis and Related Disorders.  46. 2020
2020 CTNI-10. MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104)Neuro-Oncology.  22:ii43-ii43. 2020
2020 Correction to: “Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective Multicenter Cohort Study of Imaging Selection” (Annals of Neurology, (2020), 87, 3, (419-433), 10.1002/ana.25669)Annals of Neurology.  88:1056-1057. 2020
2020 Effect size – one size doesn't fit allMultiple Sclerosis and Related Disorders.  46. 2020
2020 Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosisMultiple Sclerosis and Related Disorders.  46. 2020
2020 Timing of initiation of renal-replacement therapy in acute kidney injuryNew England Journal of Medicine.  383:1796. 2020
2020 A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: A Neurofibromatosis Clinical Trials Consortium studyNeuro-Oncology.  22:1527-1535. 2020
2020 Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets 2020
2020 Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsyEpilepsy and Behavior.  111. 2020
2020 Design and baseline data of a randomized trial comparing two methods for scaling-up an occupational sun protection interventionContemporary Clinical Trials.  97. 2020
2020 Gender differences in quality of life among patients with myasthenia gravis in ChinaHealth and Quality of Life Outcomes.  18. 2020
2020 Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United StatesJournal of Clinical Neuromuscular Disease.  22:11-21. 2020
2020 Sales to apparently alcohol-intoxicated customers and online responsible vendor training in recreational cannabis stores in a randomized trialInternational Journal of Drug Policy.  83. 2020
2020 Évaluation des valeurs de l’index des anticorps anti–JCV chez des patients atteints de SEP traités par natalizumab avec une extension de l’intervalle de dose par rapport à l’intervalle de dose standard : une analyse de la base de données TOUCH®Revue Neurologique.  176:S125. 2020
2020 Minimal manifestation status and prednisone withdrawal in the MGTX trialNeurology.  95:E755-E766. 2020
2020 Ofatumumab versus Teriflunomide in Multiple Sclerosis.New England Journal of Medicine.  383:546-557. 2020
2020 Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialNeurology.  95:E446-E456. 2020
2020 Aggressive multiple sclerosis (1): Towards a definition of the phenotype 2020
2020 Aggressive multiple sclerosis (2): Treatment 2020
2020 Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX studyMuscle and Nerve.  62:261-266. 2020
2020 Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis 2020
2020 Early Cardiac and Cerebral Hemodynamics with Umbilical Cord Milking Compared with Delayed Cord Clamping in Infants Born PretermJournal of Pediatrics.  223:51-56.e1. 2020
2020 Patient-centered outcomes and key study procedure finalization in the pilot feasibility gout randomized trial: Comparative feasibility study in GOUt, CHerry extract versus diet modification (Mini-GOUCH) 2020
2020 Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis ComplexPediatric Neurology.  109:39-46. 2020
2020 Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis 2020
2020 Reply to: Exercise for “Sleep Rehabilitation” in Parkinson's DiseaseMovement Disorders.  35:1286. 2020
2020 Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to ExerciseCell.  181:1464-1474. 2020
2020 A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout 2020
2020 A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout. 2020
2020 Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseMovement Disorders.  35:947-958. 2020
2020 Study protocol: Improving cognition in people with progressive multiple sclerosis: A multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)BMC Neurology.  20. 2020
2020 Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QDMultiple Sclerosis and Related Disorders.  40. 2020
2020 Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping with Death or Severe Intraventricular Hemorrhage among Preterm InfantsObstetrical and Gynecological Survey.  75:212-214. 2020
2020 Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United StatesNeurology.  94:495-500. 2020
2020 Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging SelectionAnnals of Neurology.  87:419-433. 2020
2020 EFFECT size or statistical significance, where to put your moneyMultiple Sclerosis and Related Disorders.  38. 2020
2020 Using practice effects for targeted trials or sub-group analysis in Alzheimer’s disease: How practice effects predict change over timePLoS One.  15. 2020
2020 Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1Annals of Clinical and Translational Neurology.  7:245-249. 2020
2020 Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsTherapeutic Advances in Neurological Disorders.  13. 2020
2020 Feasibility of “Sit Less, Move More”: An intervention for reducing sedentary behavior Among African Americans with MSMultiple Sclerosis Journal - Experimental, Translational and Clinical.  6. 2020
2020 Fertility restoration of maize CMS-C altered by a single amino acid substitution within the Rf4 bHLH transcription factor 2020
2020 Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple SclerosisMultiple Sclerosis and Related Disorders.  37. 2020
2020 Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging InitiativeJournal of Alzheimer's Disease.  76:691-701. 2020
2020 Rett syndrome: Novel correlations linking >96% genotype, disease severity, and seizures 2020
2019 Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorderJournal of Neurodevelopmental Disorders.  11. 2019
2019 199 Changes in natalizumab exposure and PML incidence over timeJournal of Neurology, Neurosurgery and Psychiatry.  90:e50. 2019
2019 Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatmentMuscle and Nerve.  60:707-715. 2019
2019 Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysisMuscle and Nerve.  60:700-706. 2019
2019 Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosisContemporary Clinical Trials.  87. 2019
2019 Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1Annals of Clinical and Translational Neurology.  6:2555-2565. 2019
2019 Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational studyEpilepsia.  60:2428-2436. 2019
2019 Association of umbilical cord milking vs delayed umbilical cord clamping with death or severe intraventricular hemorrhage among preterm infantsJournal of the American Medical Association.  322:1877-1886. 2019
2019 ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIALNeuro-Oncology.  21:vi8-vi8. 2019
2019 ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIALNeuro-Oncology.  21:vi8-vi8. 2019
2019 Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial 2019
2019 Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingNeurology.  93:e1452-e1462. 2019
2019 Functional gastrointestinal disorders negatively affect health-related quality of life in MSNeurology: Clinical Practice.  9:381-390. 2019
2019 Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients with Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) StudyJAMA Neurology.  76:1147-1156. 2019
2019 The Virtual Short Physical Performance Battery: Psychometric Properties and Validation in Older Adults With Multiple SclerosisJournal of Applied Gerontology.  38:1492-1505. 2019
2019 Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access ProgramEpilepsy and Behavior.  98:201-206. 2019
2019 Early complement genes are associated with visual system degeneration in multiple sclerosis 2019
2019 Biogeochemical controls of surface ocean phosphateScience Advances.  5. 2019
2019 Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissionsAmerican Journal of Respiratory and Critical Care Medicine.  200:511-513. 2019
2019 Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsyEpilepsy and Behavior.  97:105-110. 2019
2019 Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMSMultiple Sclerosis and Related Disorders.  33:13-21. 2019
2019 Quality of Care for Veterans With In-Hospital Stroke.Federal practitioner : for the health care professionals of the VA, DoD, and PHS.  36:365-369. 2019
2019 Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trialCancer Research.  79:ct233-ct233. 2019
2019 Examining the impact of refractory myasthenia gravis on healthcare resource utilization in the United States: Analysis of a myasthenia gravis foundation of america patient registry sample 2019
2019 O1‐09‐03: SEX IS NOT AN IMPORTANT PREDICTOR OF CHANGE IN ALZHEIMER'S CLINICAL TRIAL OUTCOMESAlzheimer's and Dementia.  15:p217-p218. 2019
2019 P3‐548: PROGRESSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE IN CANCER SURVIVORSAlzheimer's and Dementia.  15:p1183-p1183. 2019
2019 Tuberous Sclerosis Complex Genotypes and Developmental PhenotypePediatric Neurology.  96:58-63. 2019
2019 Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side EffectsNeuromodulation.  22:456-464. 2019
2019 Evaluation of a web-based fall prevention program among people with multiple sclerosisMultiple Sclerosis and Related Disorders.  31:151-156. 2019
2019 Impact of Refractory Myasthenia Gravis on Health-Related Quality of LifeJournal of Clinical Neuromuscular Disease.  20:173-181. 2019
2019 Implementation of Occupational Sun Safety at a 2-Year Follow-Up in a Randomized Trial: Comparison of Sun Safe Workplaces Policy Intervention to Attention ControlAmerican Journal of Health Promotion.  33:683-697. 2019
2019 Multiple sclerosis: Clinical trial design 2019Current Opinion in Neurology.  32:358-364. 2019
2019 Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple SclerosisContemporary Clinical Trials.  81:110-122. 2019
2019 The association of fatigue and social participation in multiple sclerosis as assessed using two different instrumentsMultiple Sclerosis and Related Disorders.  31:165-172. 2019
2019 Hand stereotypies: Lessons from the Rett Syndrome Natural History StudyNeurology.  92:E2594-E2603. 2019
2019 The Emerging Gait Dysfunction Phenotype in Idiopathic Parkinson’s Disease 2019
2019 An intervention for changing sedentary behavior among African Americans with multiple sclerosis: ProtocolJMIR Research Protocols.  8. 2019
2019 Clinical trials in multiple sclerosis: potential future trial designsTherapeutic Advances in Neurological Disorders.  12. 2019
2019 Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b 2019
2019 Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaborationAmerican Psychologist.  74:356-367. 2019
2019 Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over timeRevue Neurologique.  175:s96-s97. 2019
2019 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing ProgramRevue Neurologique.  175:s102. 2019
2019 Validation of the SymptoMScreen with performance-based or clinician-assessed outcomesMultiple Sclerosis and Related Disorders.  29:86-93. 2019
2019 A new way to estimate neurologic disease prevalence in the United States: Illustrated with MSNeurology.  92:469-480. 2019
2019 The prevalence of MS in the United States: A population-based estimate using health claims dataNeurology.  92:E1029-E1040. 2019
2019 Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trialLancet Neurology.  18:259-268. 2019
2019 Abstract 111: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core and Early PresentationStroke.  50. 2019
2019 Abstract 164: Early Infarct Growth Correlates With Both Collateral Status and Clinical Outcomes After ThrombecomyStroke.  50. 2019
2019 Abstract 4: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core Lesions on Either Simple CT or Perfusion ImagesStroke.  50. 2019
2019 Abstract TMP16: IV tPA Does Not Delay Endovascular Thrombectomy and is Associated With Improved Clinical OutcomesStroke.  50. 2019
2019 Abstract WMP9: Does Repeat Images Improve Patient Selection and Clinical Outcomes in Patients Transferred for Endovascular Thrombectomy?Stroke.  50. 2019
2019 Abstract WP75: Ischemic Core Volume Modifies the Association Between ASPECT Score and Clinical OutcomeStroke.  50. 2019
2019 Evolution of clinical trials in multiple sclerosisTherapeutic Advances in Neurological Disorders.  12. 2019
2019 Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialMuscle and Nerve.  59:201-207. 2019
2019 CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipientsPediatric Transplantation.  23. 2019
2019 Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complexEpilepsia.  60:1721-1732. 2019
2019 LB 1: Premature Infants Receiving Cord Milking or Delayed Cord Clamping: A Randomized Controlled Non-inferiority TrialAmerican Journal of Obstetrics and Gynecology.  220:s682. 2019
2019 Multicenter, prospective, phase II and biomarker study of high-dose bevacizumab as induction therapy in patients with neurofibromatosis type 2 and progressive vestibular schwannomaJournal of Clinical Oncology.  37:3446-3454. 2019
2019 Use of eHealth and mHealth technology by persons with multiple sclerosisMultiple Sclerosis and Related Disorders.  27:13-19. 2019
2018 A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depressionnpj Digital Medicine.  1. 2018
2018 High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complexJournal of epilepsy.  148:1-7. 2018
2018 Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical TrialsArchives of Physical Medicine and Rehabilitation.  99:2637-2648. 2018
2018 Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosisNeurology: Clinical Practice.  8:472-481. 2018
2018 Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosisBMJ Open.  8. 2018
2018 An Intervention for Changing Sedentary Behavior Among African Americans With Multiple Sclerosis: Protocol (Preprint) 2018
2018 Association of Concomitant Use of Cholinesterase Inhibitors or Memantine with Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysisJAMA Network Open.  1. 2018
2018 Gender differences in prednisone adverse effects Survey result from the MG registry 2018
2018 Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot StudyArthritis Care and Research.  70:1653-1660. 2018
2018 Divergent effects of AKI to CKD models on inflammation and fibrosis 2018
2018 Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective studyEpilepsy and Behavior.  87:131-136. 2018
2018 PND93 - THE IMPACT OF MYASTHENIA GRAVIS (MG) ON HEALTHCARE RESOURCE UTILIZATION: EMPIRICAL EVIDENCE FROM A US REGISTRY SAMPLEValue in Health.  21:s344. 2018
2018 The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability 2018
2018 An introduction to Mendelian randomization with applications in neurologyMultiple Sclerosis and Related Disorders.  24:72-78. 2018
2018 Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMSContemporary Clinical Trials.  71:154-161. 2018
2018 Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registryMuscle and Nerve.  58:90-98. 2018
2018 Mortality in neuromyelitis optica is strongly associated with African ancestry 2018
2018 P4‐015: RACIAL AND ETHNIC DIFFERENCES IN CONCOMITANT USE OF CHOLINESTERASE INHIBITORS AND MEMANTINE IN ALZHEIMER'S CLINICAL TRIALSAlzheimer's and Dementia.  14:p1437-p1437. 2018
2018 NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDYNeuro-Oncology.  20:i142-i142. 2018
2018 NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDYNeuro-Oncology.  20:i143-i143. 2018
2018 NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDYNeuro-Oncology.  20:i144-i144. 2018
2018 071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch® prescribing programJournal of Neurology, Neurosurgery and Psychiatry.  89:a29. 2018
2018 A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry 2018
2018 Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distributionPLoS One.  13. 2018
2018 NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDYNeuro-Oncology.  20:i142-i142. 2018
2018 NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDYNeuro-Oncology.  20:i143-i143. 2018
2018 NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDYNeuro-Oncology.  20:i144-i144. 2018
2018 Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study.Journal of Clinical Oncology.  36:2056-2056. 2018
2018 A survey of dietary characteristics in a large population of people with multiple sclerosisMultiple Sclerosis and Related Disorders.  22:12-18. 2018
2018 Results of a Randomized Trial on an Intervention Promoting Adoption of Occupational Sun Protection PoliciesAmerican Journal of Health Promotion.  32:1042-1053. 2018
2018 Cerebellar volume as an imaging marker of development in infants with tuberous sclerosis complex.Neurology.  90:e1493-e1500. 2018
2018 Factors associated with excessive sitting time in multiple sclerosisMultiple Sclerosis and Related Disorders.  21:71-77. 2018
2018 Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal StudyArchives of Clinical Neuropsychology.  34:152-161. 2018
2018 Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE 2018
2018 Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World FunctionNeurorehabilitation and Neural Repair.  32:223-232. 2018
2018 Understanding and preventing loss to follow-up: Experiences from the spinal cord injury model systemsTopics in Spinal Cord Injury Rehabilitation.  24:97-109. 2018
2018 Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studiesHypertension.  71:326-335. 2018
2018 Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosisMultiple Sclerosis and Related Disorders.  20:16-21. 2018
2018 Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver HoefEpilepsy and Behavior.  (in press). 2018
2018 Clinical trials in multiple sclerosis: milestonesTherapeutic Advances in Neurological Disorders.  11. 2018
2018 Diet quality is associated with disability and symptom severity in multiple sclerosisNeurology.  90:E1-E11. 2018
2018 DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.Open Heart.  5:e000780. 2018
2018 Learning from the past: Reflections on recently completed myasthenia gravis trialsAnnals of the New York Academy of Sciences.  1412:5-13. 2018
2018 National estimates of self-reported sitting time in adults with multiple sclerosisMultiple Sclerosis Journal - Experimental, Translational and Clinical.  4. 2018
2018 Neurofibromatosis Clinical Trial ConsortiumJournal of Child Neurology.  33:82-91. 2018
2018 Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment eraTherapeutic Advances in Neurological Disorders.  11. 2018
2018 Sun safe workplaces: Effect of an occupational skin cancer prevention program on employee sun safety practicesJournal of Occupational and Environmental Medicine.  60:990-997. 2018
2017 A Randomized Trial of an Advanced Sun Safety Intervention for Vacationers at 41 North American Resorts 2017
2017 Pedestrian safety in patients with Parkinson's disease: A case-control studyMovement Disorders.  32:1748-1755. 2017
2017 Presentation and diagnosis of tuberous sclerosis complex in infantsPediatrics.  140. 2017
2017 RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDYNeuro-Oncology.  19:vi215-vi215. 2017
2017 Cell-based therapeutic strategies for multiple sclerosis. 2017
2017 Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 yearsMultiple Sclerosis and Related Disorders.  18:95-102. 2017
2017 RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDYNeuro-Oncology.  19:vi215-vi215. 2017
2017 Correction to: Prevalence odds ratio versus prevalence ratio: choice comes with consequences: Prevalence odds ratio versus prevalence ratio (Statistics in Medicine, (2016), 35, 30, (5730-5735), 10.1002/sim.7059)Statistics in Medicine.  36:3760. 2017
2017 Challenging Assumptions About African American Participation in Alzheimer Disease TrialsAmerican Journal of Geriatric Psychiatry.  25:1150-1159. 2017
2017 Clinical trial design for progressive MS trials 2017
2017 The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic MalignancyOpen Forum Infectious Diseases.  4:s289-s289. 2017
2017 Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis ComplexPediatric Neurology.  75:80-86. 2017
2017 Author response: High hypothetical interest in physician-assisted death in multiple sclerosisNeurology.  89:1429-1430. 2017
2017 Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemiaPediatric Nephrology.  32:1565-1573. 2017
2017 Interactions between cannabidiol and commonly used antiepileptic drugsEpilepsia.  58:1586-1592. 2017
2017 Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?Multiple Sclerosis Journal - Experimental, Translational and Clinical.  3. 2017
2017 Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's diseaseJournal of Neuroimmunology.  309:100-110. 2017
2017 Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot studyOsteoporosis International.  28:2495-2503. 2017
2017 Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5)Osteoporosis International.  28:2505. 2017
2017 Perspectives on marijuana use and effectiveness: A survey of NARCOMS participantsNeurology: Clinical Practice.  7:333-343. 2017
2017 Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyAnnals of Clinical and Translational Neurology.  4:466-477. 2017
2017 [O4–03–05]: CONCOMITANT USE OF CHOLINESTERASE INHIBITORS OR MEMANTINE IS ASSOCIATED WITH COGNITIVE DECLINE IN ALZHEIMER's CLINICAL TRIALSAlzheimer's and Dementia.  13:p1234-p1234. 2017
2017 Adjunctive Azithromycin Prophylaxis for Cesarean Delivery 2017
2017 Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note 2017
2017 Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: Results of a matching-adjusted indirect comparisonJournal of Comparative Effectiveness Research.  6:313-323. 2017
2017 Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resortsPreventive Medicine.  99:29-36. 2017
2017 Employment and absenteeism in working-age persons with multiple sclerosis 2017
2017 Influence of seizures on early development in tuberous sclerosis complex.Epilepsy and Behavior.  70:245-252. 2017
2017 Publication outcomes of abstracts from the American Society of Hematology Annual MeetingAmerican Journal of Hematology.  92:E81-E83. 2017
2017 The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's diseaseBrain Stimulation.  10:651-656. 2017
2017 High hypothetical interest in physician-assisted death in multiple sclerosisNeurology.  88:1528-1534. 2017
2017 Assessment of Caregiver Inventory for Rett SyndromeJournal of Autism and Developmental Disorders.  47:1102-1112. 2017
2017 Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple SclerosisResearch in Nursing and Health.  40:143-152. 2017
2017 Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosisMultiple Sclerosis and Related Disorders.  13:87-92. 2017
2017 Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratificationNeurology.  88:1197-1205. 2017
2017 Prevalence of Sun Protection at Outdoor Recreation and Leisure Venues at Resorts in North AmericaAmerican Journal of Health Education.  48:90-99. 2017
2017 Association between early childhood caries and colonization with streptococcus mutans genotypes from mothersPediatric Dentistry.  39:130-135. 2017
2017 Effects of Subthalamic Nucleus Deep Brain Stimulation on Objective Sleep Outcomes in Parkinson's DiseaseMovement Disorders Clinical Practice.  4:183-190. 2017
2017 Continuous electroencephalography (cEEG) monitoring and outcomes of critically Ill patients 2017
2017 Adjunctive Azithromycin Prophylaxis for Cesarean DeliveryObstetrical and Gynecological Survey.  72:71-73. 2017
2017 Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypothesesMultiple Sclerosis and Related Disorders.  12:70-78. 2017
2017 A framework of care in multiple sclerosis, part 2: Symptomatic care and beyondInternational Journal of MS Care.  19:42-56. 2017
2017 Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set 2017
2017 Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment 2017
2017 Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosisInternational Journal of MS Care.  19:240-246. 2017
2016 Prevalence odds ratio versus prevalence ratio: choice comes with consequencesStatistics in Medicine.  35:5730-5735. 2016
2016 Clinical trials: To catch a crook, you might try statisticsNature Reviews Neurology.  13:9-10. 2016
2016 Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1Neurology.  87:2575-2584. 2016
2016 International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15rMuscle and Nerve.  54:1015-1022. 2016
2016 Sustained High Level of Healthcare Worker Adherence with Hand Hygiene Practice Recommendations Using the Patient-as-Observer Approach in the Ambulatory SettingInfection Control and Hospital Epidemiology.  37:1496-1498. 2016
2016 The authors replyNew England Journal of Medicine.  375:2006-2007. 2016
2016 Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MSNeurology: Clinical Practice.  6:397-408. 2016
2016 Long-term evolution of multiple sclerosis disability in the treatment eraAnnals of Neurology.  80:499-510. 2016
2016 Adjunctive azithromycin prophylaxis for cesarean deliveryNew England Journal of Medicine.  375:1231-1241. 2016
2016 Laquinimod efficacy in relapsing-remitting multiple sclerosis: How to understand why and if studies disagreeBMC Neurology.  16. 2016
2016 T cell cytokine signatures: Biomarkers in pediatric multiple sclerosisJournal of Neuroimmunology.  297:1-8. 2016
2016 Randomized trial of thymectomy in myasthenia gravisNew England Journal of Medicine.  375:511-522. 2016
2016 Health insurance affects the use of disease-modifying therapy in multiple sclerosisNeurology.  87:365-374. 2016
2016 Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error? 2016
2016 O4‐05‐06: Limitations of the Fda‐Approved ‘Ad Clinical Trial Simulation Tool’Alzheimer's and Dementia.  12:p344-p344. 2016
2016 P3‐012: Advancing Therapeutics for Neuroinflammation in Alzheimer's Disease: Clinical Development ConsiderationsAlzheimer's and Dementia.  12:p822-p822. 2016
2016 Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialJournal of the Neurological Sciences.  365:190-198. 2016
2016 Placebo-controlled study in neuromyelitis optica - Ethical and design considerations 2016
2016 Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trialsInternational Journal of Obesity.  40:895-898. 2016
2016 Analysis of diagnoses associated with multiple sclerosis-related in-hospital mortality using the premier hospital databaseInternational Journal of MS Care.  18:154-161. 2016
2016 Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple SclerosisJournal of Neuroimaging.  26:296-302. 2016
2016 Statistical Considerations for an Adaptive Design for a Serious Rare DiseaseTherapeutic Innovation & Regulatory Science.  50:375-384. 2016
2016 Recommendations for observational studies of comorbidity in multiple sclerosis.Neurology.  86:1446-1453. 2016
2016 The challenge of comorbidity in clinical trials for multiple sclerosis.Neurology.  86:1437-1445. 2016
2016 Long-term registriesNeurology: Clinical Practice.  6:97-99. 2016
2016 Relationship between symptom change, relapse activity and disability progression in multiple sclerosisJournal of the Neurological Sciences.  362:121-126. 2016
2016 Relapses in multiple sclerosis: Relationship to disabilityMultiple Sclerosis and Related Disorders.  6:10-20. 2016
2016 Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical TrialsJournal of Alzheimer's Disease.  50:1205-1215. 2016
2016 Extended interval dosing of natalizumab in multiple sclerosisJournal of Neurology, Neurosurgery and Psychiatry.  87:885-889. 2016
2016 3: Azithromycin-based extended spectrum antibiotic prophylaxis for non-elective cesarean delivery: a pragmatic multicenter placebo-controlled double-blind rctAmerican Journal of Obstetrics and Gynecology.  214:s3. 2016
2016 A framework of care in multiple sclerosis, part 1: Updated disease classification and disease-modifying therapy use in specific circumstancesInternational Journal of MS Care.  18:314-323. 2016
2016 Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex InfantsPediatric Neurology.  54:29-34. 2016
2016 Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical centerJournal of Hospital Medicine.  11:15-20. 2016
2016 Maternal BMI Associations with Maternal and Cord Blood Vitamin D Levels in a North American Subset of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Participants.PLoS One.  11:e0150221. 2016
2016 Pooling Morphometric Estimates: A Statistical Equivalence ApproachJournal of Neuroimaging.  26:109-115. 2016
2016 Randomized trial of thymectomy in myasthenia gravisJournal of Thoracic Disease.  8:E1782-E1783. 2016
2016 Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environmentsContemporary Clinical Trials.  46:67-76. 2016
2015 Prevalence and incidence of early childhood caries among African-American children in AlabamaJournal of Public Health Dentistry.  75:42-48. 2015
2015 Sustained use of an occupational sun safety program in a recreation industry: follow-up to a randomized trial on dissemination strategiesTranslational Behavioral Medicine.  5:361-371. 2015
2015 Systematic review of interventional sickle cell trials registered in ClinicalTrials.govClinical Trials.  12:575-583. 2015
2015 Abstract 19094: Use of ACE Inhibitors or Angiotensin Receptor Blockers is Associated With a Significantly Lower Risk of 30-day All-cause and Heart Failure Readmissions and All-cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure Developing Acute Kidney InjuryCirculation.  132. 2015
2015 Capacity of patients with brain metastases to make treatment decisions 2015
2015 Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.Value in Health.  18:A750. 2015
2015 Defining reliable disability outcomes in multiple sclerosis 2015
2015 Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims databaseMultiple Sclerosis and Related Disorders.  4:546-554. 2015
2015 Two-group time-to-event continual reassessment method using likelihood estimationContemporary Clinical Trials.  45:340-345. 2015
2015 Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment 2015
2015 Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change? 2015
2015 Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort studyHuman Brain Mapping.  36:3749-3760. 2015
2015 Causes of death among persons with multiple sclerosisMultiple Sclerosis and Related Disorders.  4:484-490. 2015
2015 Factors associated with early childhood caries incidence among high caries-risk childrenCommunity Dentistry and Oral Epidemiology.  43:366-374. 2015
2015 Pooling morphometric estimates: a statistical equivalence approach 2015
2015 VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohortsJournal of Rehabilitation Research and Development.  52:263-272. 2015
2015 Translation of a Ski School Sun Safety Program to North American Ski and Snowboard SchoolsHealth Promotion Practice.  16:560-570. 2015
2015 O1‐10‐02: How does differential effect of treatment in ApoE‐ɛ4+ carriers change clinical trial design in Alzheimer's disease?Alzheimer's and Dementia.  11:p154-p154. 2015
2015 To treat or not to treat, that really is not the questionNeurology: Clinical Practice.  5:253-258. 2015
2015 The promise of futility trials in neurological diseasesNature Reviews Neurology.  11:300-305. 2015
2015 Impact of multiple sclerosis relapse: The NARCOMS participant perspectiveMultiple Sclerosis and Related Disorders.  4:234-240. 2015
2015 Multiple sclerosis drugs: How much bang for the buck?Lancet Neurology.  14:460-461. 2015
2015 Risk tolerance to MS therapies: Survey results from the NARCOMS registryMultiple Sclerosis and Related Disorders.  4:241-249. 2015
2015 Marijuana Usage and Disability in MS in the NARCOMS RegistryNeurology.  April 06, 2015; 84 (14 Supplement):P1.140-P1.140. 2015
2015 Differences in Alzheimer disease clinical trial outcomes based on age of the participantsNeurology.  84:1121-1127. 2015
2015 A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis 2015
2015 A systematic review of the incidence and prevalence of cancer in multiple sclerosis 2015
2015 A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis 2015
2015 A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview 2015
2015 A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis 2015
2015 The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review 2015
2015 The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review 2015
2015 Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMSContemporary Clinical Trials.  41:69-74. 2015
2015 Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center dataMultiple Sclerosis and Related Disorders.  4:124-136. 2015
2015 Abstract W P270: Quality of In-Hospital Stroke Care in Veterans Affairs HospitalsStroke.  46. 2015
2015 A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy ControlsNeuroInformatics.  13:7-18. 2015
2015 Care partners and multiple sclerosis: Differential effect on men and womenInternational Journal of MS Care.  17:253-260. 2015
2015 Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: A cross-sectional surveyBMJ Open.  5. 2015
2015 Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS RegistryNeurodegenerative Disease Management.  5:3-10. 2015
2015 The sustainability of an occupational skin cancer prevention programJournal of Occupational and Environmental Medicine.  57:1207-1213. 2015
2014 Chronobiology of Hypertension in Sickle Cell DiseaseBlood.  124:4094-4094. 2014
2014 Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributions 2014
2014 Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newbornsJournal of Pediatrics.  165:1104-1108.e1. 2014
2014 Pubertal development in rett syndrome deviates from typical femalesPediatric Neurology.  51:769-775. 2014
2014 No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple SclerosisAdvances in Therapy.  31:1134-1154. 2014
2014 Composite end points to assess delay of disability progression by MS treatments 2014
2014 Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related itemsBMC Neurology.  14. 2014
2014 Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activationJournal of Infectious Diseases.  210:1155-1165. 2014
2014 Cognition in patients with newly diagnosed brain metastasis: Profiles and implicationsJournal of Neuro-Oncology.  120:179-185. 2014
2014 A-75Financial Decline in Patients with Mild Cognitive Impairment: A Six-year Longitudinal StudyArchives of Clinical Neuropsychology.  29:530-531. 2014
2014 Abstract 327: The Choice of Diuretic is Important in the Treatment of Resistant HypertensionHypertension.  64. 2014
2014 Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence? 2014
2014 Causes of death among commercially insured multiple sclerosis patients in the United StatesPLoS One.  9. 2014
2014 Defining the clinical course of multiple sclerosis: The 2013 revisionsNeurology.  83:278-286. 2014
2014 Patient perspectives on switching disease-modifying therapies in the NARCOMS registryPatient Preference and Adherence.  8:971-979. 2014
2014 P2‐393: THE USE OF META‐DATABASE DATA FOR QUALITY CONTROL IN CLINICAL TRIALS: AN EXAMPLE USING THE MMSEAlzheimer's and Dementia.  10:p623-p623. 2014
2014 P4‐176: DIFFERENCES IN ALZHEIMER DISEASE CLINICAL TRIALS OUTCOMES BASED ON AGE OF PATIENTSAlzheimer's and Dementia.  10:p853-p853. 2014
2014 P4‐177: BASELINE COGNITIVE SEVERITY DOES NOT PREDICT RATE OF CHANGE IN THE ADAS‐COG CLINICAL TRIALSAlzheimer's and Dementia.  10:p853-p854. 2014
2014 Bifactor structure of clinical disability in relapsing multiple sclerosisMultiple Sclerosis and Related Disorders.  3:176-185. 2014
2014 Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Neurology.  13:247-256. 2014
2014 Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.Kidney International.  85:513-521. 2014
2014 Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation servicesJournal of Public Health Management and Practice.  20. 2014
2014 Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failureAmerican Journal of Medicine.  127:132-139. 2014
2014 Clinical trials in multiple sclerosisHandbook of Clinical Neurology.  122:445-453. 2014
2014 Dissemination of go sun smart in outdoor recreation: effect of program exposure on sun protection of guests at high-altitude ski areas. 2014
2014 Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Muscle and Nerve.  49:483-486. 2014
2014 Does natalizumab therapy benefit patients with multiple sclerosis?JAMA Neurology.  71:945-946. 2014
2014 EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: A randomised, double-blind, placebo-controlled phase 2 clinical trial 2014
2014 Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's diseaseAlzheimer's and Dementia.  10:349-359. 2014
2014 Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failureJournal of Pediatrics.  164:744-748. 2014
2014 Health literacy association with health behaviors and health care utilization in multiple sclerosis: A cross-sectional study 2014
2014 Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumabMultiple Sclerosis and Related Disorders.  3:505-512. 2014
2014 In replyJAMA Psychiatry.  71:339-340. 2014
2014 Intensive care unit readmission during childhood after preterm birth with respiratory failureJournal of Pediatrics.  164. 2014
2014 Mutans streptococci enumeration and genotype selection using different bacitracin-containing mediaJournal of Microbiological Methods.  103:53-57. 2014
2014 Natalizumab reduces relapse clinical severity and improves relapse recovery in MSMultiple Sclerosis and Related Disorders.  3:705-711. 2014
2014 Recruitment of participants to a multiple sclerosis trial: The CombiRx experienceClinical Trials.  11:159-166. 2014
2014 Seabed classification using surface backscattering strength versus acoustic frequency and incidence angle measured with vertical, split-beam echosounders 2014
2014 Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.Multiple Sclerosis and Related Disorders.  3:364-371. 2014
2013 Natural history of multiple sclerosis symptomsInternational Journal of MS Care.  15:146-158. 2013
2013 Sampling selectivity in acoustic-trawl surveys of Pacific sardine (Sardinops sagax) biomass and length distribution 2013
2013 Cost-effectiveness analyses Beauty and the beast?Neurology: Clinical Practice.  3:436-439. 2013
2013 Establishing the burden of Carbon monoxide exposure in private homes 2013
2013 Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American populationAmyotrophic lateral sclerosis & frontotemporal degeneration.  14:334-337. 2013
2013 Mortality in patients with multiple sclerosisNeurology.  81:184-192. 2013
2013 A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravisMuscle and Nerve.  48:76-84. 2013
2013 MRI lesions: A surrogate for relapses in multiple sclerosis?Lancet Neurology.  12:628-630. 2013
2013 O4–05–06: Effect of sample size re‐estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairmentAlzheimer's and Dementia.  9:p691-p691. 2013
2013 P1–360: Effect of APOE genotype on clinical trial outcomesAlzheimer's and Dementia.  9:p290-p290. 2013
2013 Characteristics of Streptococcus mutans genotypes and dental caries in childrenEuropean Journal of Oral Sciences.  121:148-155. 2013
2013 Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.Annals of Neurology.  73:705-713. 2013
2013 Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine AdsorbedPLoS One.  8. 2013
2013 Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972))BMJ Open.  3. 2013
2013 Outcomes of screening mammography by frequency, breast density, postmenopausal hormone therapyJAMA Internal Medicine.  173:807-816. 2013
2013 Constraint-induced movement therapy for the lower extremities in multiple sclerosis: Case series with 4-year follow-upArchives of Physical Medicine and Rehabilitation.  94:753-760. 2013
2013 Disability in multiple sclerosis: A reference for patients and cliniciansNeurology.  80:1018-1024. 2013
2013 Randomized study combining interferon and glatiramer acetate in multiple sclerosisAnnals of Neurology.  73:327-340. 2013
2013 Reported mammographic density: film-screen versus digital acquisition.Radiology.  266:752-758. 2013
2013 Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center studyNeuroImage: Clinical.  2:120-131. 2013
2013 "Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registry 2013
2013 A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation 2013
2013 A retrospective review of lithium usage in veterans with multiple sclerosisMultiple Sclerosis and Related Disorders.  2:327-333. 2013
2013 EDSS variability before randomization may limit treatment discovery in primary progressive MS 2013
2013 Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumabEuropean Journal of Neurology.  20:87-94. 2013
2013 Effect of physical comorbidities on risk of depression in Multiple SclerosisInternational Journal of MS Care.  15:34-43. 2013
2013 Indoor carbon monoxide: a case study in England for detection and interventions to reduce population exposure.Journal of Environmental and Public Health.  2013:735952. 2013
2013 National variation of technical factors in computed tomography of the head 2013
2013 Preferred sources of health information in persons with multiple sclerosis: Degree of trust and information sought 2013
2013 ReplyMuscle and Nerve.  47:145-146. 2013
2013 Substantial burden of dizziness in multiple sclerosisMultiple Sclerosis and Related Disorders.  2:21-28. 2013
2013 The Multiple Sclerosis Intimacy and Sexuality Questionnaire - Re-validation and development of a 15-item version with a large US sample 2013
2013 The magnetic resonance imaging 'rule of five': Predicting the occurrence of relapse 2013
2013 Treatment trials in progressive MS - Current challenges and future directionsNature Reviews Neurology.  9:496-503. 2013
2012 Biomarker positive and negative subjects in the ADNI cohort: Clinical characterizationCurrent Alzheimer Research.  9:1135-1141. 2012
2012 Cause of death in MS: Long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b studyBMJ Open.  2. 2012
2012 Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer.Molecular Therapy.  20:2234-2243. 2012
2012 Personalized medicine: The return of the house call?Neurology: Clinical Practice.  2:343-351. 2012
2012 Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesContemporary Clinical Trials.  33:1211-1216. 2012
2012 No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosisAmerican Journal of Neuroradiology.  33:1913-1917. 2012
2012 Treatment with interferon beta for multiple sclerosisJournal of the American Medical Association.  308:1627. 2012
2012 Short latency activation of cortex by clinically effective thalamic brain stimulation for tremorMovement Disorders.  27:1404-1412. 2012
2012 Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States 2012
2012 Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures. 2012
2012 Sustainability of the Dissemination of an Occupational Sun Protection Program in a Randomized TrialHealth Education and Behavior.  39:498-502. 2012
2012 Increasing age at disability milestones among MS patients in the MSBase RegistryJournal of the Neurological Sciences.  318:94-99. 2012
2012 Evolution of MS lesions to black holes under DNA vaccine treatmentJournal of Neurology.  259:1375-1382. 2012
2012 Adopting an evidence-based lifestyle physical activity program: Dissemination study design and methodsTranslational Behavioral Medicine.  2:199-208. 2012
2012 Psychometric evaluation of the myasthenia gravis composite using rasch analysisMuscle and Nerve.  45:820-825. 2012
2012 Recommendations for myasthenia gravis clinical trialsMuscle and Nerve.  45:909-917. 2012
2012 Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's diseaseMovement Disorders.  27:864-873. 2012
2012 Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.Lancet Neurology.  11:467-476. 2012
2012 The CombiRx Trial: A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Participants with Relapsing-Remitting Multiple Sclerosis - Clinical Outcomes (PL02.003)Neurology.  78:pl02.003-pl02.003. 2012
2012 High Frequency and Adverse Impact of Vertigo and Dizziness in Multiple Sclerosis (P07.075)Neurology.  78:p07.075-p07.075. 2012
2012 Mortality in Multiple Sclerosis in the United States (MIMS-US): A Retrospective, Cohort Study of Survival and Mortality Trends (P06.195)Neurology.  78:p06.195-p06.195. 2012
2012 Natural History of MS Symptoms: Perceived Disease Impact across Disease Span in Nine Neurologic Domains among Enrollees in North American Research Committee on Multiple Sclerosis (NARCOMS) Registry (P07.073)Neurology.  78:p07.073-p07.073. 2012
2012 A Genetic Model Predicts the Response to Glatiramer Acetate in Two Different Cohorts (P05.129)Neurology.  78:p05.129-p05.129. 2012
2012 Clinical Outcomes and Cause of Death for Interferon Beta-1b Versus Placebo, 21 Years Following Randomization (P04.129)Neurology.  78:p04.129-p04.129. 2012
2012 Psychometric Evaluation of Quality of Life (QoL) and Disease Severity Outcome Measures in Myasthenia Gravis (MG) Using Rasch Analysis (P05.174)Neurology.  78:p05.174-p05.174. 2012
2012 Relationship between Symptom Worsening, Relapse Activity and Disease Progression in Patients with Multiple Sclerosis (P05.094)Neurology.  78:p05.094-p05.094. 2012
2012 A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (S20.003)Neurology.  78:s20.003-s20.003. 2012
2012 Survival in MS A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trialNeurology.  78:1315-1322. 2012
2012 The CombiRx Trial: A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Participants with Relapsing Remitting Multiple Sclerosis - MRI Outcomes (S11.002)Neurology.  78:s11.002-s11.002. 2012
2012 A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (IN3-2.003)Neurology.  78:in3-2.003-in3-2.003. 2012
2012 Amyotrophic Lateral Sclerosis in a Large African American Population, Does It Differ from Caucasians? (P01.098)Neurology.  78:p01.098-p01.098. 2012
2012 Improvements in the Power of Detecting Treatment Effect in a Primary Progressive Multiple Sclerosis (PPMS) Clinical Trial with the Use of Composite Disability Outcome Endpoints (P01.151)Neurology.  78:p01.151-p01.151. 2012
2012 The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics.Multiple Sclerosis and Related Disorders.  1:81-86. 2012
2012 Cumulative impact of comorbidity on quality of life in MSActa Neurologica Scandinavica.  125:180-186. 2012
2012 Expanding occupational sun safety to an outdoor recreation industry: A translational study of the Go Sun Smart programTranslational Behavioral Medicine.  2:10-18. 2012
2012 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes.Diabetes reviews (Alexandria, Va.).  35:574-580. 2012
2012 Implementing clinical trials on an international platform: Challenges and perspectivesJournal of the Neurological Sciences.  313:1-6. 2012
2012 Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models.NeuroImage.  59:2155-2166. 2012
2012 Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data.NeuroImage.  59:2217-2230. 2012
2012 Response to the Letter 'Efficiency loss due to varying cluster sizes in cluster randomized trials and how to compensate for it: Comment on You et al. (2011)' by van Breukelen and CandelClinical Trials.  9:126-127. 2012
2012 Biomarker development for myasthenia gravisAnnals of the New York Academy of Sciences.  1275:101-106. 2012
2012 Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areasJournal of the American Academy of Dermatology.  66:63-70. 2012
2012 Enhancing industry-based dissemination of an occupational sun protection program with theory-based strategies employing personal contactAmerican Journal of Health Promotion.  26:356-365. 2012
2012 Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancerMolecular Therapy.  20:2234-2243. 2012
2012 Statistical cures and other fallacies 2012
2012 The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristicsMultiple Sclerosis and Related Disorders.  1:81-86. 2012
2012 Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's diseaseParkinsonism and Related Disorders.  18:63-68. 2012
2011 Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosisNeurology.  77:2089-2096. 2011
2011 Re: Practice parameters in myasthenia gravisMuscle and Nerve.  44:1001. 2011
2011 Real-time quantitative polymerase chain reaction for enumeration of Streptococcus mutans from oral samplesEuropean Journal of Oral Sciences.  119:447-454. 2011
2011 Reply from the authorsNeurology.  77. 2011
2011 To the editorNeurology.  77. 2011
2011 A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.Neurology.  77:1551-1560. 2011
2011 Randomized trial of oral teriflunomide for relapsing multiple sclerosis.New England Journal of Medicine.  365:1293-1303. 2011
2011 Inhaled nitric oxide in preterm infants: An individual-patient data meta-analysis of randomized trialsPediatrics.  128:729-739. 2011
2011 Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PDBrain and Behavior.  1:12-18. 2011
2011 Erratum: Estimating power with effect size versus slope differences: Both means and variance matter (Alzheimer's and Dementia (2011) 7 (247-249))Alzheimer's and Dementia.  7:556. 2011
2011 Motivating public school districts to adopt sun protection policies: A randomized controlled trialAmerican Journal of Preventive Medicine.  41:309-316. 2011
2011 Association between comorbidity and clinical characteristics of MSActa Neurologica Scandinavica.  124:135-141. 2011
2011 Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MSNeurology.  77:138-144. 2011
2011 A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphomaJournal of Veterinary Internal Medicine.  25:890-896. 2011
2011 Got milk?Annals of Neurology.  70:3-4. 2011
2011 O4‐01‐03: Amnestic MCI/ prodromal Alzheimer's disease with more severe memory deficit is indistinguishable from diagnosed Alzheimer disease: Implications for the validity of clinical trials and biomarkersAlzheimer's and Dementia.  7:s681-s682. 2011
2011 A research model for investigating the effects of artificial food colorings on children with ADHDPediatrics.  127. 2011
2011 Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: Evidence from a cross-sectional analysisNeuroepidemiology.  36:183-191. 2011
2011 Bayesian sample size determination under hypothesis testsContemporary Clinical Trials.  32:393-398. 2011
2011 Factors That Predict Adoption and Implementation of an Evidence-based Physical Activity ProgramMedicine and Science in Sports and Exercise.  43:694. 2011
2011 Practice parameters and focusing research: Plasma exchange for myasthenia gravisMuscle and Nerve.  43:625-626. 2011
2011 The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.Pain Medicine.  12:697-705. 2011
2011 Interferon β-1b and glatiramer acetate effects on permanent black hole evolutionNeurology.  76:1222-1228. 2011
2011 Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseasesNeuroepidemiology.  36:85-90. 2011
2011 Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. 2011
2011 Continued benefits of a technical assistance web site to local tobacco control coalitions during a state budget shortfallJournal of Public Health Management and Practice.  17. 2011
2011 Estimating power with effect size versus slop differences: Both means and variance matterAlzheimer's and Dementia.  7:247-249. 2011
2011 Estimating the density of Antarctic krill (Euphausia superba) from multi-beam echo-sounder observations using distance sampling methods 2011
2011 Genetic diversity of plaque mutans streptococci with rep-PCR 2011
2011 Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patientsPLoS One.  6. 2011
2011 Relative efficiency and sample size for cluster randomized trials with variable cluster sizesClinical Trials.  8:27-36. 2011
2011 Risk of serious injury for young baseball pitchers: A 10-year prospective studyAmerican Journal of Sports Medicine.  39:253-257. 2011
2011 Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenationPediatric Critical Care Medicine.  12. 2011
2011 Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis 2011
2011 Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approachBone.  49:356-367. 2011
2011 Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis 2011
2011 Supporting tobacco control: stimulating local newspaper coverage with a technical assistance website for local coalitions.Health Promotion Practice.  12. 2011
2011 Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium 2011
2010 Assessing changes in relapse rates in multiple sclerosis 2010
2010 Comparative analysis of therapeutic options used for myasthenia gravisAnnals of Neurology.  68:797-805. 2010
2010 Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia.Pediatrics.  126:e1545-e1552. 2010
2010 Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcomaBMC Cancer.  10. 2010
2010 Disability progression in a clinical trial of relapsing-remitting multiple sclerosis eight-year follow-upJAMA Neurology.  67:1329-1335. 2010
2010 Environmental cues to UV radiation and personal sun protection in outdoor winter recreationJAMA Dermatology.  146:1241-1247. 2010
2010 Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.JAMA Neurology.  67:1370-1378. 2010
2010 Composite MRI scores improve correlation with EDSS in multiple sclerosis 2010
2010 Poster 230: Hand Function, Mobility, and Employment Status in the NARCOMS Registry 2010
2010 Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trialsAlzheimer's and Dementia.  6:367-377. 2010
2010 Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity 2010
2010 Temporal characteristics of cold pain perceptionNeuroscience Letters.  480:12-15. 2010
2010 O2‐02‐08: Requiring a CSF amyloid‐β42 biomarker for a prodromal AD research diagnosis does not result in better clinical trials: Simulations from the ADNI databaseAlzheimer's and Dementia.  6:s100-s100. 2010
2010 Stenting versus endarterectomy for treatment of carotid-artery stenosisNew England Journal of Medicine.  363:11-23. 2010
2010 Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisAnnals of Neurology.  67:749-760. 2010
2010 Reply from the authorsNeurology.  74:1554-1555. 2010
2010 Variability of two plaque sampling methods in quantitation of streptococcus mutansCaries Research.  44:160-164. 2010
2010 Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factorsJournal of Clinical Epidemiology.  63:441-451. 2010
2010 Inhaled Nitric Oxide in preterm infants: A systematic review and individual patient data meta-analysisBMC Pediatrics.  10. 2010
2010 Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Longitudinal, Magnetic Resonance Imaging, Blinded Pilot StudyJournal of Vascular Surgery.  51:794. 2010
2010 292 CONSTRAINT-INDUCED MOVEMENT THERAPY FOR IMPAIRED GAIT IN PROGRESSIVE MS: 1-YEAR FOLLOW-UPParkinsonism and Related Disorders.  16:s83. 2010
2010 Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MSCurrent Medical Research and Opinion.  26:493-500. 2010
2010 A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisTherapeutic Advances in Neurological Disorders.  3:15-28. 2010
2010 Considerations on discontinuing natalizumab for the treatment of multiple sclerosisAnnals of Neurology.  68:409-411. 2010
2010 Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint 2010
2010 Reproducibility of high-resolution optical coherence tomography in multiple sclerosis 2010
2010 Sample size in obesity trials: Patient perspective versus current practiceMedical Decision Making.  30:68-75. 2010
2010 Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisNeurology.  74:1041-1047. 2010
2009 Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031)Journal of Neuroimmunology.  217:103. 2009
2009 Evidence of treatment benefit: Is seeing believing or obfuscation by statistics? 2009
2009 Weight changes associated with unilateral STN DBS and advanced PDParkinsonism and Related Disorders.  15:709-711. 2009
2009 Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea.Pain.  146:91-98. 2009
2009 Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 yearPediatrics.  124:1333-1343. 2009
2009 Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trialArthritis and Rheumatism.  60:3207-3216. 2009
2009 Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosisJAMA Neurology.  66:1366-1372. 2009
2009 A bayesian method of estimating kappa coefficient with application to a rheumatoid arthritis study 2009
2009 FP39-WE-01 Long-term follow-up 20 years after the pivotal interferon beta-1b multiple sclerosis trialJournal of the Neurological Sciences.  285:s118-s119. 2009
2009 Vision related quality of life in multiple sclerosis: Correlation with new measures of low and high contrast letter acuityJournal of Neurology, Neurosurgery and Psychiatry.  80:767-772. 2009
2009 Testing a theory-based health communication program: A replication of go sun smart in outdoor winter recreation 2009
2009 Variability of interpretive accuracy among diagnostic mammography facilities 2009
2009 Measuring up rates for adverse health behaviors in multiple sclerosis: The need for action 2009
2009 Proof of concept studies for tissue-protective agents in multiple sclerosis 2009
2009 Multibeam echosounder observations reveal interactions between Antarctic krill and air-breathing predators 2009
2009 Retinal architecture predicts pupillary reflex metrics in MS 2009
2009 Factors that influence adherence with disease-modifying therapy in MSJournal of Neurology.  256:568-576. 2009
2009 Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma 2009
2009 Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stressMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis.  674:93-100. 2009
2009 The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and undertreated 2009
2009 Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approachAnnals of Neurology.  65:268-275. 2009
2009 MHC-dependent desensitization of intrinsic anti-self reactivity 2009
2009 Predictors of radiologists' perceived risk of malpractice lawsuits in breast imagingAmerican Journal of Roentgenology.  192:327-333. 2009
2009 Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts dataComputational Statistics and Data Analysis.  53:820-833. 2009
2009 Comorbidity delays diagnosis and increases disability at diagnosis in MSNeurology.  72:117-124. 2009
2009 High frequency of adverse health behaviors in multiple sclerosis 2009
2009 A cross-sectional study of bone health in multiple sclerosisNeurology.  73:1394-1398. 2009
2009 Differences in Bladder Care for Veterans with Multiple Sclerosis by Treatment LocationInternational Journal of MS Care.  11:91-97. 2009
2009 Editorial: Relapses in multiple sclerosis: Important or not?Neurology.  73:1612-1613. 2009
2009 Effect of Physical Comorbidities on Risk of Depression in Multiple SclerosisInternational Journal of MS Care.  11:161-165. 2009
2008 Optical coherence tomography: A window into the mechanisms of multiple sclerosisNature Reviews Neurology.  4:664-675. 2008
2008 Comorbidity, socioeconomic status and multiple sclerosis 2008
2008 Construction of an efficient evaluative instrument for myasthenia gravis: The MG compositeMuscle and Nerve.  38:1553-1562. 2008
2008 Smoking status over two years in patients with multiple sclerosisNeuroepidemiology.  32:72-79. 2008
2008 Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis: ReplyNeurology.  71:1747-1748. 2008
2008 Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings 2008
2008 Effects of program exposure and engagement with tailored prevention communication on sun protection by young adolescents 2008
2008 Go Sun SmartCommunication Education.  57:423-433. 2008
2008 Testing the long-term effects of the Go Sun Smart worksite health communication campaign: A group-randomized experimental studyJournal of Communication.  58:447-471. 2008
2008 The MGTX experience: Challenges in planning and executing an international, multicenter clinical trialJournal of Neuroimmunology.  201-202:80-84. 2008
2008 Bayesian interim analysis in clinical trialsContemporary Clinical Trials.  29:751-755. 2008
2008 Novel design for clinical trials in multiple sclerosis: Another excursion to Sirenum scopuli?Clinical Practice.  5:613-622. 2008
2008 Reproducibility of optical coherence tomography in multiple sclerosisJAMA Neurology.  65:1218-1222. 2008
2008 Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravisMuscle and Nerve.  38:957-963. 2008
2008 Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses 2008
2008 Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosisJAMA Neurology.  65:924-928. 2008
2008 Increasing Sun Protection in Winter Outdoor Recreation. A Theory-Based Health Communication ProgramAmerican Journal of Preventive Medicine.  34:502-509. 2008
2008 Mammography facility characteristics associated with interpretive accuracy of screening mammography 2008
2008 Hyperglycemia and adverse pregnancy outcomesNew England Journal of Medicine.  358:1991-2002. 2008
2008 Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. 2008
2008 Randomized trial evaluating computer-based sun safety education for children in elementary schoolJournal of Cancer Education.  23:74-79. 2008
2008 Randomized trial on the 5 a day, the Rio Grande way website, a web-based program to improve fruit and vegetable consumption in rural communities 2008
2008 Randomized trials on consider this, a tailored, internet-delivered smoking prevention program for adolescentsHealth Education and Behavior.  35:260-281. 2008
2008 Corticospinal tract abnormalities are associated with weakness in multiple sclerosisAmerican Journal of Neuroradiology.  29:333-339. 2008
2008 Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessmentNeurology.  70:1134-1140. 2008
2008 Responsiveness and predictive values in PPMS: An uncertain messageNeurology.  70:1061-1062. 2008
2008 Rules of evidence for clinical trials: The science of finding the truth?Annals of the New York Academy of Sciences.  1132:233-237. 2008
2008 Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisoneAnnals of the New York Academy of Sciences.  1132:344-347. 2008
2008 Validation of NARCOMS Depression ScaleInternational Journal of MS Care.  10:81-84. 2008
2007 Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphomaVeterinary Pathology.  44:467-478. 2007
2007 Validation of the NARCOMS registry: Diagnosis 2007
2007 Disparities in the management of multiple sclerosis-related bladder symptomsNeurology.  68:1971-1978. 2007
2007 Testing the risk compensation hypothesis for safety helmets in alpine skiing and snowboardingInjury Prevention.  13:173-177. 2007
2007 Randomized trial on sun safety education at ski and snowboard schools in western North AmericaPediatric Dermatology.  24:222-229. 2007
2007 Influence of computer-aided detection on performance of screening mammographyNew England Journal of Medicine.  356:1399-1409. 2007
2007 Interferon-β for multiple sclerosis: Long-term benefits?Annals of Neurology.  61:283-285. 2007
2007 Effect of emailed messages on return use of a nutrition education website and subsequent changes in dietary behavior 2007
2007 Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trialAnnals of Neurology.  61:14-24. 2007
2007 Optical coherence tomography and disease subtype in multiple sclerosisNeurology.  69:2085-2092. 2007
2007 Persistent pain and uncomfortable sensations in persons with multiple sclerosisPain.  127:35-41. 2007
2007 Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma [7]Leukemia.  21:184-187. 2007
2007 Relation of vision to global and regional brain MRI in multiple sclerosisNeurology.  69:2128-2135. 2007
2007 Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosisNeurology.  69:1603-1609. 2007
2006 Mediation of a middle school skin cancer prevention programHealth Psychology.  25:616-625. 2006
2006 Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory FailureNew England Journal of Medicine.  355:354-364. 2006
2006 Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiationExperimental Hematology.  34:870-878. 2006
2006 Reality check: Perceived versus actual performance of community mammographersAmerican Journal of Roentgenology.  187:42-46. 2006
2006 Naturally occurring translational models for development of cancer gene therapyGene therapy & molecular biology.  10:31-40. 2006
2006 Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: Results from the IMPACT study 2006
2006 Does multiple sclerosis-associated disability differ between races?Neurology.  66:1235-1240. 2006
2006 Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosisJAMA Neurology.  63:614-619. 2006
2006 Futility studies: Spending a little to save a lotNeurology.  66:626-627. 2006
2006 Impact of customized videotape education on quality of life in patients with chronic obstructive pulmonary diseaseJournal of Cardiopulmonary Rehabilitation and Prevention.  26:112-117. 2006
2006 Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis [3]Neurology.  66:954. 2006
2006 Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An updateObesity Reviews.  7:79-88. 2006
2006 Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis 2006
2006 Effects of the Sunny Days, Healthy Ways curriculum on students in grades 6 to 8American Journal of Preventive Medicine.  30:13-22. 2006
2006 Infectious causes of multiple sclerosisLancet Neurology.  5:887-894. 2006
2005 Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients 2005
2005 Changes in the ascertainment of multiple sclerosisNeurology.  65:1066-1070. 2005
2005 MRI as a marker for disease heterogeneity in multiple sclerosisNeurology.  65:1071-1076. 2005
2005 Validation of the NARCOMS Registry: Fatique assessment 2005
2005 Can We Improve Resting Energy Expenditure (REE) Predictions Using a Pooled Data Set and New Formulas?Journal of the Academy of Nutrition and Dietetics.  105:17. 2005
2005 Randomized trial testing a worksite sun protection program in an outdoor recreation industryHealth Education and Behavior.  32:514-535. 2005
2005 Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable riskCancer Research.  65:5654-5661. 2005
2005 Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammographyRadiology.  236:37-46. 2005
2005 Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirensStroke.  36:1622-1623. 2005
2005 The Goldman Consensus statement on depression in multiple sclerosis 2005
2005 Validation of the NARCOMS registry: Pain assessment 2005
2005 Current realities of delivering mammography services in the community: Do challenges with staffing and scheduling exist?Radiology.  235:391-395. 2005
2005 Mammographers' perception of women's breast cancer riskMedical Decision Making.  25:283-289. 2005
2005 Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosisNeurology.  64:992-995. 2005
2005 Physician predictors of mammographic accuracy 2005
2005 Assessing accuracy of mammography in the presence of verification bias and intrareader correlationBiometrics.  61:259-268. 2005
2005 Association between mammography timing and measures of screening performance in the United StatesRadiology.  234:363-373. 2005
2005 Community-based mammography practice: Services, charges, and interpretation methodsAmerican Journal of Roentgenology.  184:433-438. 2005
2005 Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?International Journal of Obesity.  29:443-446. 2005
2005 Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement IssuesInternational Journal of MS Care.  7:129-131. 2005
2005 Randomized effectiveness trial of a computer-assisted intervention to improve diabetes careDiabetes reviews (Alexandria, Va.).  28:33-39. 2005
2004 Accuracy of screening mammography interpretation by characteristics of radiologists 2004
2004 A practical randomized trial to improve diabetes careJournal of General Internal Medicine.  19:1167-1174. 2004
2004 Prevalence and diffusion of helmet use at ski areas in Western North America in 2001-02Injury Prevention.  10:358-362. 2004
2004 CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's diseaseJournal of the Neurological Sciences.  225:79-83. 2004
2004 Clinical characteristics of progressive relapsing multiple sclerosis 2004
2004 Effect of breast augmentation on the accuracy of mammography and cancer characteristicsWomen's Oncology Review.  4:163-164. 2004
2004 The MS Co-Operative Research (MS-CORE) group: An alternate approach to fostering multicenter studies [1] 2004
2004 The association between obesity and screening mammography accuracyJAMA Internal Medicine.  164:1140-1147. 2004
2004 Radiologist uncertainty and the interpretation of screeningMedical Decision Making.  24:255-264. 2004
2004 The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite 2004
2004 Effect of Breast Augmentation on the Accuracy of Mammography and Cancer CharacteristicsJournal of the American Medical Association.  291:442-450. 2004
2004 The Practical Use of Charts to Estimate Resting Energy Expenditure in AdultsTopics in Clinical Nutrition.  19:51-56. 2004
2003 Effect of relapses on development of residual deficit in multiple sclerosisNeurology.  61:1528-1532. 2003
2003 Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened populationJournal of Clinical Oncology.  21:4314-4321. 2003
2003 Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeNeurology.  61:1367-1373. 2003
2003 Enhancing antimelanoma immune responses through apoptosisCancer Gene Therapy.  10:726-736. 2003
2003 A randomized controlled study of the acute and chronic effects of cooling therapy for MS.Neurology.  60:1955-1960. 2003
2003 Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis 2003
2003 Optimization of technique factors for a silicon diode array full-field digital mammography system and comparison to screen-film mammography with matched average glandular doseMedical Physics.  30:334-340. 2003
2003 Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammographyACP journal club.  138:168-175. 2003
2003 Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis 2003
2003 The prevalence and predictors of helmet use by skiers and snowboarders at ski areas in western north america in 2001Journal of Trauma and Acute Care Surgery.  55:939-945. 2003
2002 Eight-year follow-up study of brain atrophy in patients with MSNeurology.  59:1412-1420. 2002
2002 Detection of ductal carcinoma in situ in women undergoing screening mammography 2002
2002 Benefit of interferon β-1a on MSFC progression in secondary progressive MSNeurology.  59:679-687. 2002
2002 Performance of diagnostic mammography for women with signs or symptoms of breast cancer 2002
2002 Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancerAmerican Journal of Roentgenology.  179:671-677. 2002
2002 Mammography screening and differences in stage of disease by race/ethnicityAmerican Journal of Public Health.  92:1144-1150. 2002
2002 Performance comparison of full-field digital mammography to screen-film mammography in clinical practiceMedical Physics.  29:830-834. 2002
2002 The Multiple Sclerosis Functional Composite: A new clinical outcome measure for multiple sclerosis trials 2002
2001 Modelling new enhancing MRI lesion counts in multiple sclerosis 2001
2001 Competing demands in the office visit: What influences mammography recommendations? 2001
2001 Use of the multiple sclerosis functional composite to predict disability in relapsing MSNeurology.  56:1324-1330. 2001
2001 Hypothermia as a risk factor for pediatric cardiothoracic surgical site infection 2001
2001 Comparison of full-field digital mammography with screen-film mammography for cancer detection: Results of 4,945 paired examinationsRadiology.  218:873-880. 2001
2001 Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic settingAmerican Journal of Roentgenology.  176:1241-1248. 2001
2001 The effect of degree of refractive error on hydrogel contact lens-induced complications and patient self-management behaviorsOptometry and Vision Science.  78:652-656. 2001
2001 Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trialJAMA Neurology.  58:961-967. 2001
2000 Performance of screening mammography among women with and without a first-degree relative with breast cancerACP journal club.  133:855-863. 2000
2000 Clinical significance of the multiple sclerosis functional composite: Relationship to patient-reported quality of lifeJAMA Neurology.  57:1319-1324. 2000
2000 Intrarater and interrater reliability of the MS functional composite outcome measureNeurology.  54:802-806. 2000
2000 Validity of self-reported colorectal cancer screening behaviorCancer Epidemiology, Biomarkers and Prevention.  9:229-232. 2000
2000 New low-contrast vision charts: Reliability and test characteristics in patients with multiple sclerosis 2000
2000 Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patients 2000
2000 Self-reported visual dysfunction in multiple sclerosis: Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25) 2000
1999 Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial 1999
1999 The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. 1999
1999 Development of a multiple sclerosis functional composite as a clinical trial outcome measure 1999
1999 The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment 1999
1999 A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites 1999
1999 Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network. 1999
1999 Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: The design of two randomized trialsPreventive Medicine.  28:229-242. 1999
1998 The prospective relationships between smoking and weight in a young, biracial cohort: The Coronary Artery Risk Development in Young Adults studyJournal of Consulting and Clinical Psychology.  66:987-993. 1998
1998 Improvement in mammography quality control: 1987-1995Radiology.  207:663-668. 1998
1998 Pathogenetic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the ratCarcinogenesis.  19:223-227. 1998
1998 The cancer information service research consortium: An emerging laboratory for cancer control researchPreventive Medicine.  27. 1998
1998 The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease [1] (multiple letters)Obstetrics and Gynecology.  91:156-157. 1998
1997 The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal diseaseObstetrics and Gynecology.  90:347-352. 1997
1997 Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.Journal of Pediatrics.  131:55-62. 1997
1997 THE EFFECTS OF TECHNIQUE VARIATIONS ON KNEE BIOMECHANICS DURING THE SQUAT AND LEG PRESS 887Medicine and Science in Sports and Exercise.  29:156. 1997
1997 Impact of Maternal Group B Streptococcal Screening on Pediatric Management in Full-Term NewbornsObstetrical and Gynecological Survey.  52:168-169.. 1997
1997 Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS)Journal of the American College of Cardiology.  29:358-364. 1997
1997 A classification system to evaluate weight maintainers, gainers, and losersJournal of the Academy of Nutrition and Dietetics.  97:481-488. 1997
1997 Evaluating the value of low-vision services. 1997
1997 Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newbornJournal of Pediatrics.  131:55-62. 1997
1997 Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceAnnals of Neurology.  42:379-382. 1997
1996 RANDOMIZED, MULTICENTER TRIAL OF INHALED NITRIC OXIDE AND HIGH FREQUENCY OSCILLATORY VENTILATION IN SEVERE PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN). • 1315Pediatric Research.  39:222-222. 1996
1996 Clinical outcomes assessment in multiple sclerosisAnnals of Neurology.  40:469-479. 1996
1996 Clinical outcomes assessment in multiple sclerosis: Part II 1996
1996 Impact of maternal group B streptococcal screening on pediatric management in full-term newbornsJAMA Pediatrics.  150:802-808. 1996
1996 Methodological issues in weight cyclingAnnals of Behavioral Medicine.  18:280-289. 1996
1996 The clinical presentation, prevalence, and risk factors of focal corneal infiltrates in soft contact lens wearers 1996
1995 A CASE CONTROL STUDY OF RISK FACTORS IN DEVELOPMENT OF FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAINING.Optometry and Vision Science.  72:90. 1995
1995 CLINICAL PRESENTATION AND SYMPTOMATOLOGY OF PATIENTS WITH FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAININGOptometry and Vision Science.  72:89. 1995
1995 ETHNICITY AS A RISK FACTOR FOR CONTACT LENS RELATED BIOMICRO-SCOPIC SIGNS.Optometry and Vision Science.  72:89. 1995
1995 Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysisACOG Current Journal Review.  8:18-19. 1995
1995 The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants.Journal of Perinatology.  15:185-191. 1995
1995 Psychological correlates of weight fluctuation.International Journal of Eating Disorders.  17:263-275. 1995
1995 Optometric Care and Undetected Eye Disease: A Case of Berkson's Bias?JAMA Internal Medicine.  155:427-429. 1995
1995 Optometric care and undetected eye disease: a case of Berkson's bias?Archives of Internal Medicine.  155:427-427. 1995
1995 Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth.American Journal of Obstetrics and Gynecology.  172:666-671. 1995
1995 A new device for collecting cord bloodObstetrics and Gynecology.  86:850-852. 1995
1995 Cervical examination and tocodynamometry at 28 weeks' gestation: Prediction of spontaneous preterm birthAmerican Journal of Obstetrics and Gynecology.  172:666-671. 1995
1995 Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosisAnnals of Neurology.  37:5-6. 1995
1995 Differences in the detection and enumeration of mutans streptococci due to differences in methodsArchives of Oral Biology.  40:345-351. 1995
1995 Fetal growth in women using low-dose aspirin for the prevention of preeclampsia: Effect of maternal sizeJournal of Maternal-Fetal Medicine.  4:218-224. 1995
1995 Impact of patient history on residents' evaluation of child sexual abuseChild Abuse and Neglect.  19:943-951. 1995
1995 Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortalityObstetrics and Gynecology.  85:1055-1058. 1995
1995 Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trialAmerican Journal of Obstetrics and Gynecology.  173:578-584. 1995
1995 Psychological correlates of weight fluctuationInternational Journal of Eating Disorders.  17:263-275. 1995
1995 The Effect of Cigarette Smoking on Neonatal Anthropometric MeasurementsObstetrics and Gynecology.  85:625-630. 1995
1995 The relationship between maternal and neonatal anthropometric measurements in term newbornsObstetrics and Gynecology.  85:192-196. 1995
1995 The self-management behaviors of soft contact lens wearers: The effect of lens modalityInternational contact lens clinic (New York, N.Y.).  22:117-123. 1995
1995 Who Are the Weight Maintainors?Obesity.  3:249s-259s. 1995
1994 A study of the reliability and comparative validity of the cardia dietary history. 1994
1994 CLINICAL PRESENTATION, PREVALENCE AND RISK FACTORS OF FOCAL INFILTRATES IN GENERAL EYE CARE PRACTICESOptometry and Vision Science.  71:76. 1994
1994 LENS CARE SYSTEMS, COMPLIANCE, AND CONTACT LENS-RELATED SIGNS AND SYMPTOMSOptometry and Vision Science.  71:98. 1994
1994 SELF-MANAGEMENT AMONG CONTACT LENS WEARERS: DIFFERENCES BETWEEN DISPOSABLE AND CONVENTIONAL LENS WEARERSOptometry and Vision Science.  71:158. 1994
1994 THE EFFECT OF THE DEGREE OF REFRACTIVE ERROR ON HYDROGEL CONTACT LENS WEAROptometry and Vision Science.  71:77. 1994
1994 Bed rest in pregnancyObstetrics and Gynecology.  84:131-136. 1994
1994 Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetesSouthern Medical Journal.  87:616-620. 1994
1994 Data discrepancies and audit effects in the umbilical artery catheter trialTherapeutic Innovation & Regulatory Science.  28:891-897. 1994
1994 Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart diseaseAmerican Journal of Public Health.  84:951-956. 1994
1994 Effect of a National Cancer Institute Clinical Alert on breast cancer practice patternsJournal of Clinical Oncology.  12:1783-1788. 1994
1994 Low‐dose aspirin therapy to prevent preeclampsiaInternational Journal of Gynecology and Obstetrics.  44:97-97. 1994
1994 Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysisObstetrics and Gynecology.  83:483-494. 1994
1993 Rose Questionnaire responses among black and white inpatients admitted for coronary heart disease: findings from the Birmingham-BHS Project. 1993
1993 Elevated levels of midtrimester maternal serum‐fetoprotein are associated with preterm delivery but not with fetal growth retardationInternational Journal of Gynecology and Obstetrics.  41:219-219. 1993
1993 Fetal biparietal diameter, head circumference, abdominal circumference and femur length: A comparison by race and sex 1993
1993 Promoting physical activity in low-income African-American communities: the PARR project. 1993
1993 Initial Acquisition of Mutans Streptococci by Infants: Evidence for a Discrete Window of Infectivity 1993
1993 Low-dose aspirin therapy to prevent preeclampsiaAmerican Journal of Obstetrics and Gynecology.  168:1083-1093. 1993
1993 Maternal risk factors and their influence on fetal anthropometric measurementsAmerican Journal of Obstetrics and Gynecology.  168:1197-1205. 1993
1993 Physical activity of public housing residents in Birmingham, AlabamaAmerican Journal of Public Health.  83:1016-1020. 1993
1993 Radiographic Changes Associated with Tracheal Isolation of Ureaplasma Urealyticum from NeonatesClinical Infectious Diseases.  17:S122-S130. 1993
1993 The feasibility of long-term treatment of diabetes with continuous subcutaneous insulin infusionDiabetes, nutrition & metabolism.  6:57-60. 1993
1993 The relationship between maternal hematocrit and pregnancy outcome: black-white differences.Journal of the National Medical Association.  85:130-134. 1993
1993 Transmission of mutans streptococci to infants following short term application of an iodine‐NaF solution to mothers' dentitionCommunity Dentistry and Oral Epidemiology.  21:136-142. 1993
1992 Serum folate and fetal growth retardation: a matter of compliance?Obstetrics and Gynecology.  79:719-722. 1992
1992 Blood pressure, growth retardation, and preterm deliveryInternational Journal of Technology Assessment in Health Care.  8:82-90. 1992
1992 Distributed data analysis in a multicenter study: The CARDIA studyContemporary Clinical Trials.  13:80-90. 1992
1992 Effect of conventional dental restorative treatment on bacteria in salivaCommunity Dentistry and Oral Epidemiology.  20:138-143. 1992
1992 Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardationAmerican Journal of Obstetrics and Gynecology.  167:596-601. 1992
1992 Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic maleUrology.  40:36-40. 1992
1992 Maternal serum folate and zinc concentrations and their relationships to pregnancy outcomeAmerican Journal of Clinical Nutrition.  56:365-370. 1992
1992 Relationship of intraventricular hemorrhage or death with the level of umbilical artery catheter placement: A multicenter randomized clinical trialPediatrics.  90:881-887. 1992
1992 Serum folate and fetal growth retardation: A matter of compliance?Obstetrics and Gynecology.  79:719-722. 1992
1992 Symptom-limited graded treadmill exercise testing in young adults in the CARDIA studyMedicine and Science in Sports and Exercise.  24:177-183. 1992
1992 The influence of previous low birth weight on birth weight, gestational age, and anthropometric measurements in the current pregnancyObstetrics and Gynecology.  79:276-280. 1992
1992 The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardationObstetrics and Gynecology.  80:262-267. 1992
1992 Usefulness of various maternal skinfold measurements for predicting newborn birth weightJournal of the Academy of Nutrition and Dietetics.  92:1393-1394. 1992
1991 Black-white differences in newborn anthropometric measurements.Obstetrics and Gynecology.  78:782-788. 1991
1991 Cardiovascular risk factors in young adults. The CARDIA baseline monograph.Contemporary Clinical Trials.  12:1S-77S. 1991
1991 Black-white differences in newborn anthropometric measurementsObstetrics and Gynecology.  78:782-788. 1991
1991 Cardiovascular risk factors in young adults. The CARDIA baseline monographContemporary Clinical Trials.  12:1-77. 1991
1991 Maternal serum alpha2-macroglobulin and fetal growth retardationObstetrics and Gynecology.  78:594-599. 1991
1991 Oral leukoplakia and adolescent smokeless tobacco useOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.  72:35-41. 1991
1991 Risk factors and the natural history of coronary heart disease in blacksCardiovascular clinics.  21:29-45. 1991
1991 The relationship between maternal hematocrit and pregnancy outcomeObstetrics and Gynecology.  77:190-194. 1991
1991 The relationship between maternal serum zinc levels during pregnancy and birthweightEarly Human Development.  25:75-85. 1991
1990 Intrauterine growth retardation and preterm delivery: Prenatal risk factors in an indigent populationInternational Journal of Gynecology and Obstetrics.  33:85-85. 1990
1990 Estimating the Mean, Variance, and Confidence Limits from Censored (Limit of Detection), Lognormally-Distributed Exposure DataAIHA journal : a journal for the science of occupational and environmental health and safety.  51:416-419. 1990
1990 A positive association between maternal serum zinc concentration and birth weightAmerican Journal of Clinical Nutrition.  51:678-684. 1990
1990 Alcohol intake and blood pressure in young adults: The CARDIA studyJournal of Clinical Epidemiology.  43:1-13. 1990
1990 Cigarette smoking behavior is strongly related to educational status: The cardia studyPreventive Medicine.  19:158-169. 1990
1990 Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent populationAmerican Journal of Obstetrics and Gynecology.  162:213-218. 1990
1990 Intrauterine growth retardation is not the same as small for gestational age (I: Reply)American Journal of Obstetrics and Gynecology.  162:1643. 1990
1990 Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults StudyAmerican Journal of Public Health.  80:1053-1056. 1990
1990 ReplyAmerican Journal of Obstetrics and Gynecology.  162:1643. 1990
1990 Smoking, maternal age, fetal growth, and gestational age at deliveryAmerican Journal of Obstetrics and Gynecology.  162:53-58. 1990
1990 The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: Results of a cross-sectional study in patients from the Hypertension Detection and Follow-up ProgramJournal of Human Hypertension.  4:491-500. 1990
1990 Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm deliveryAmerican Journal of Obstetrics and Gynecology.  162:748-754. 1990
1989 Efficacy of a premixed semisynthetic human insulin regimen 1989
1989 Patient preference between clear and yellow lenses for binocular indirect ophthalmoscopyClinical eye and vision care.  1:163-165. 1989
1989 A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at BirthNew England Journal of Medicine.  320:1511-1516. 1989
1989 Effects of very low birth weights on fetal and neonatal mortality rates in AlabamaPublic Health Reports.  104:488-492. 1989
1989 Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA studyHypertension.  14:218-226. 1989
1989 Fluorescence microscopy of DES‐induced morphologic transformation in unfixed, cultured cellsJournal Of Oral Pathology and Medicine.  18:451-456. 1989
1989 Intrauterine growth retardation: Standards for diagnosisAmerican Journal of Obstetrics and Gynecology.  161:271-277. 1989
1989 Portable tonometers: a clinical comparison of applanation and indentation devices. 1989
1989 Preliminary Results From The Collaborative Alabama And Scandinavian Study Of Successive Small‐For‐Gestational Age Births: Report From a Symposium In Trondheim 9th June 1988Acta Obstetricia et Gynecologica Scandinavica.  68:19-25. 1989
1989 Prematurity, postdates, and growth retardation: The influence of use of ultrasonography on reported gestational ageAmerican Journal of Obstetrics and Gynecology.  160:462-470. 1989
1989 Sensitivity, specificity and predictive value of saliva thiocyanate among pregnant womenAddictive Behaviors.  14:447-452. 1989
1988 ASSOCIATION OF UREAPLASMA UREALYTICUM INFECTION OF THE LOWER RESPIRATORY TRACT WITH CHRONIC LUNG DISEASE AND DEATH IN VERY-LOW-BIRTH-WEIGHT INFANTS 1988
1988 A cost-effectiveness analysis of self-help smoking cessation methods for pregnant womenPublic Health Reports.  103:83-88. 1988
1988 Cardia: study design, recruitment, and some characteristics of the examined subjectsJournal of Clinical Epidemiology.  41:1105-1116. 1988
1988 Condylomata acuminata in IDDM.Diabetes reviews (Alexandria, Va.).  11:295-296. 1988
1988 Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery diseaseTherapeutic Innovation & Regulatory Science.  22:425-448. 1988
1988 Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery diseaseTherapeutic Innovation & Regulatory Science.  22:425-448. 1988
1988 Factors associated with discontinuation of continuous subcutaneous insulin infusionAmerican Journal of the Medical Sciences.  295:23-28. 1988
1988 Plasmid-containing strains of Streptococcus mutans cluster within family and racial cohorts: Implications for natural transmissionInfection and Immunity.  56:3216-3220. 1988
1988 Relationships of low density lipoprotein cholesterol with age and other factors: A cross-sectional analysis of the CARDIA studyAnnals of clinical research.  20:32-38. 1988
1987 A study of the cost of tuberculosis contact investigation related to non-tuberculous Mycobacterial isolation in Jefferson County, AlabamaPublic Health.  101:297-304. 1987
1987 Comparison of hypertension prevalence and control in 5,237 rural and urban Alabama residentsSouthern Medical Journal.  80:1220-1223. 1987
1987 Fetal deaths in Alabama, 1974-1983: A birth weight-specific analysisObstetrics and Gynecology.  70:831-835. 1987
1987 Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) studyContemporary Clinical Trials.  8:68-73. 1987
1986 Prediction of response to sodium intervention for blood pressure controlJournal of Hypertension.  4. 1986
1986 DDT contamination of a North Alabama aquatic ecosystemEnvironmental Toxicology and Chemistry.  5:725-736. 1986
1985 Low birth weight, intrauterine growth retardation, and preterm deliveryAmerican Journal of Obstetrics and Gynecology.  152:980-984. 1985
1985 The Natural History of Smoking Cessation Among Patients Undergoing Coronary ArteriographyJournal of Cardiopulmonary Rehabilitation and Prevention.  5:332???340. 1985
1985 Effective dietary intervention in hypertensives: sodium restriction and weight reduction.Journal of the Academy of Nutrition and Dietetics.  85:423-430. 1985
1985 Dietary therapy slows the return of hypertension after stopping prolonged medicationJournal of the American Medical Association.  253:657-664. 1985
1985 Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survivalAmerican Journal of Obstetrics and Gynecology.  151:608-611. 1985
1985 Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged MedicationJournal of the American Medical Association.  253:657-657. 1985
1985 Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged MedicationJournal of the American Medical Association.  253:657-664. 1985
1985 Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular functionJournal of the American College of Cardiology.  5:1036-1045. 1985
1985 The Risk of Bladder Calculi in Patients With Spinal Cord InjuriesJAMA Internal Medicine.  145:428-430. 1985
1985 The effectiveness of smoking cessation methods for smokers in public health maternity clinics: A randomized trialAmerican Journal of Public Health.  75:1389-1392. 1985
1985 The natural history of smoking cessation among patients undergoing coronary arteriographyJournal of Cardiopulmonary Rehabilitation and Prevention.  5:332-340. 1985
1984 Does effective antihypertensive therapy partially "cure" hypertension?Transactions of the American Clinical and Climatological Association.  96:111-119. 1984
1984 Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH)Journal of Hypertension.  2:179-181. 1984
1984 Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.Journal of Hypertension.  2:S179-S181. 1984
1984 Return of hypertension after withdrawal of prolonged antihypertensive therapy, effect of weight loss, sodium reduction, and baseline factors.Proceedings of the Association of American Physicians.  97:190-196. 1984
1984 Response from Findley, et alAmerican Journal of Public Health.  74:392-392. 1984
1984 Association of factor B with ischemic heart disease (IHD).Progress in clinical and biological research.  147:479-480. 1984
1984 Issues in the natural history and treatment of coronary heart disease in black populations: Surgical treatmentAmerican Heart Journal.  108:688-694. 1984
1984 The risk of renal calculi in spinal cord injury patientsInvestigative urology.  131:857-859. 1984
1983 Baseline physical examination characteristics of the hypertensive participantsHypertension.  5. 1983
1983 Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants.Hypertension.  5. 1983
1983 An assessment of the environmental protection agency's asbestos hazard evaluation algorithmAmerican Journal of Public Health.  73:1179-1181. 1983
1983 Baseline medical history characteristics of the hypertensive participantsHypertension.  5:51-91. 1983
1983 Baseline physical examination characteristics of the hypertensive participantsHypertension.  5:92-132. 1983
1983 Quasi-experimental designs for evaluating cancer control programs in rural settings.Progress in clinical and biological research.  120:55-70. 1983
1983 Training and certification of blood pressure observersHypertension.  5:610-614. 1983
1982 Epidemiologic study of candidates for coronary artery bypass surgery.Circulation.  66:III6-II15. 1982
1982 Selenium in reducing waters.Science.  217:829-831. 1982
1982 Correlates of attendance and compliance in the hypertension detection and follow-up programContemporary Clinical Trials.  3:13-27. 1982
1982 Epidemiologic study of candidates for coronary artery bypass surgeryCirculation.  66. 1982
1982 Methodological issues in using time series designs and analysis: evaluating the behavioral impact of health communication programs.Progress in clinical and biological research.  83:517-535. 1982
1982 Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the hypertension detection and follow-up program cooperative groupPreventive Medicine.  11:487-499. 1982
1982 Validation of a risk function to predict mortality in a VA population with coronary artery diseaseContemporary Clinical Trials.  3:47-60. 1982
1981 Urinary Glycosaminoglycan Excretion as a Biochemical Marker in Patients with Bladder CarcinomaCancer Research.  41:3868-3873. 1981
1981 Cohort analysis of secular change in mortality in patients with cad undergoing surgical interventionAmerican Journal of Cardiology.  47:487. 1981
1981 Increasing utilization of a rural cervical cancer detection programAmerican Journal of Public Health.  71:641-643. 1981
1980 A two-compartment regression model applied to compliance in a hypertension treatment programJournal of Clinical Epidemiology.  33:645-651. 1980
1980 Application of survival analysis techniques to evaluation of factors affecting compliance in a clinical trial of hypertension controlContemporary Clinical Trials.  1:59-69. 1980
1980 Impact of hypertension information on high blood pressure control between 1973 and 1978Hypertension.  2:708-713. 1980
1980 Mortality surveillance in collaborative trialsAmerican Journal of Public Health.  70:394-400. 1980
1978 Separate mRNAs code for tubulin subunits.Nature.  272:81-83. 1978
1976 SODIUM EXCRETION AND SYMPATHETIC ACTIVITY IN RELATION TO SEVERITY OF HYPERTENSIVE DISEASE 1976
1976 Some examples for teaching regression toward the mean from a sampling viewpointAmerican Statistician.  30:194-197. 1976
1886 Injustice to Dr. barnesJournal of the American Medical Association.  VI:498. 1886

Chapter

Year Title Altmetric
2022 Outcomes in Clinical Trials.  891-914. 2022
2017 Women and neurological disability: End-of-life care and mortality in women with MS.  113-126. 2017
2014 Association, cause, and correlation.  345-362. 2014
2012 Multiple sclerosis.  257-272. 2012
2011 Measures of neurological impairment and disability in multiple sclerosis.  56-64. 2011
2008 Association, cause, and correlation.  279-294. 2008
2008 Defining Responders and Non-responders: Clinical and Statistical Aspects. 2008
2007 Nutrition Monitoring and Research Studies.  471-480. 2007
2007 Measures of neurological impairment and disability in multiple sclerosis.  67-77. 2007
2007 Defining Responders and Non-responders.  113-125. 2007
2007 Observational Studies 2007
2001 Nutrition Monitoring and Research Studies 2001
2001 Nutrition monitoring and research studies: Observational studies.  453-462. 2001
2001 Observational Studies 2001
2001 Therapeutic considerations: Rating scales.  465-491. 2001
1984 EFFECT OF WEIGHT LOSS ON THE RETURN OF HYPERTENSION AFTER WITHDRAWAL OF PROLONGED ANTIHYPERTENSIVE THERAPY.  301-315. 1984

Principal Investigator On

  • CMSC/NARCOMS Project  awarded by CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS
  • ChLorthalidone In Chronic Kidney Disease (CLICK) Study  awarded by Indiana University
  • Chronic Hypertension and Pregnancy (CHAP): Data Coordinating Center  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate (CAPTURE) Study  awarded by University of Texas Southwestern Medical Center at Dallas
  • Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)  awarded by University of Colorado
  • Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Effect of Single vs. Combination Therapy on Contrast Letter Acuity in MS Patients  awarded by National Multiple Sclerosis Society ^
  • Extension of Combination Therapy in Multiple Sclerosis (eCombiRx)  awarded by MT. SINAI MEDICAL CENTER
  • Longitudinal Study to Identify Early Biomarkers of Autism Spectrum Disorder (ASD) in Infants with Tuberous Sclerosis Complex (TSC)  awarded by Tuberous Sclerosis Alliance
  • Mechanisms of Neurodegeneration and Strategies for Neuroprotection in MS  awarded by Johns Hopkins University
  • Myasthenia Gravis Patient Registry Work Order #1  awarded by Myasthenia Gravis Foundation of America, Inc.
  • Myasthenia Gravis Patient Registry Work Order #2  awarded by Myasthenia Gravis Foundation of America, Inc.
  • Myasthenia Gravis Patient Registry Work Order #4  awarded by Myasthenia Gravis Foundation of America, Inc.
  • Myasthenia Gravis Patient Registry Work Order #5  awarded by Myasthenia Gravis Foundation of America, Inc.
  • Myasthenia Gravis Patient Registry Work Order #6  awarded by Myasthenia Gravis Foundation of America, Inc.
  • Myasthenia Gravis Patient Registry Work Order #7  awarded by Myasthenia Gravis Foundation of America, Inc.
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Collaborative Opportunities  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Non-Invasive Inhaled Nitric Oxide in Premature Newborns  awarded by University of Colorado
  • Phase I Clinical Trial in Humans using Human Fetal Derived Glial Restricted Progenitor Cells ("Q Cells") In Transverse Myelitis  awarded by THE TRAVERSE MYELITIS ASSOCIATION
  • Phase II Trial of Sildenafil in Newborns with Persistent Pulmonary Hypertension  awarded by University of Colorado
  • Premature Infants Receiving Cord Milking Or Delayed Cord Clamping  awarded by SHARP HEALTHCARE FOUNDATION
  • Private Grant  awarded by BIOGEN MA INC
  • Rare Disease Network for Myasthenia Gravis  awarded by George Washington University
  • Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve Clinical Trials Methods and Outcomes: Alzheimer Disease Clinical  awarded by University of Southern California
  • The UAB STI CRC - DiSCIS Biostatistics & Bioinformatics Core  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Thymectomy in Non-Thymomatous MG Patients on Prednisone  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Thymectomy in Non-Thymomatous MG Patients on Prednisone  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • UAB Center for AIDS Research - Biostatistics and Epidemioloogy  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research - Biostats Core D  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Pre and Post-Doctoral Training Program in Biostatistics  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Investigator On

  • 14-3-3 Phosphorylation as a Biomarker for Parkinson's Disease  awarded by Fox (Michael J.) Foundation for Parkinson's Research
  • 14-3-3 Phosphorylation as a Biomarker for Parkinson's Disease  awarded by Fox (Michael J.) Foundation for Parkinson's Research
  • 14-3-3 Phosphorylation in Parkinson’s Disease  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • 2/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • A Home-Based Couples Intervention to Enhance PMTCT and Family Health in Kenya  awarded by National Institute of Mental Health/NIH/DHHS
  • A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma  awarded by National Cancer Institute/NIH/DHHS
  • A Phase I Trial of IRS-1 HSV C134 Administered Intratumorally in Patients with Recurrent Malignant Glioma  awarded by Gateway for Cancer Research (The)
  • A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type I and Chemotherapy-Refractory Radiographic Progressive Low-Grade  awarded by Children's Tumor Foundation
  • A Pilot Study for Testing the Feasibility and Efficacy of Text Messaging and Newsletter as a Strategy for Interrupting Sedentary Behavior  awarded by CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS
  • A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients with Rheumatoid Arthritis with Active Disease Despite Methotrexate  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE
  • ACES - ACE Inhibitors Combined with Exercise for Hypertensive Seniors  awarded by National Institute on Aging/NIH/DHHS
  • AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease  awarded by National Center for Advancing Translational Sciences/NIH/DHHS
  • Acute Renal Injury Sequelae in NICU Graduates (ARISING)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Autophagy-Lysosome Pathway Function in HIV: Effects of Antiretroviral Therapy and Relevance to Neurocognitive Status  awarded by Brigham and Women's Hospital
  • Center for Pediatric-Onset Demyelinating Disease  awarded by National Multiple Sclerosis Society ^
  • Center for Translational Research on Aging and Mobility  awarded by National Institute on Aging/NIH/DHHS
  • Center for Translational Research on Aging and Mobility - Core B: Pilot Core  awarded by National Institute on Aging/NIH/DHHS
  • Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • ChLorthalidone in Chronic Kidney Disease (CLICK) Study  awarded by Indiana University
  • Changes in Visual Cortical Connectivity Following Central Visual Field Loss  awarded by National Eye Institute/NIH/DHHS
  • Childhood Follow-Up Study of Obesity and Neurodevelopment After Perinatal Exposure to Adjunctive Azithromycin Prophylaxis for Cesarean Delivery  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Childhood Pulmonary and Related Outcomes after Perinatal Exposure to Adjunctive Azithromycin Prophylaxis For Cesarean Delivery (C/SOAP Follow-up Study)  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Chronic Hypertension and Pregnancy (CHAP): Data Coordinating Center  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Chronobiology and Chronopharmacology to Prevent Sickle Cell Nephropathy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Comparative Effectiveness of an Exercise Intervention Delivered via Telerehabilitation and Conventional Mode of Delivery  awarded by SHEPHERD CENTER
  • Decisional Capacity Evaluation in Metastatic Brain Cancer  awarded by American Cancer Society, Inc.
  • Design Issues in Obesity RCTs: Building an Evidence Base  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Diagnosis of Parkinson's Disease Using Diffusion Tensor Imaging  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Early Biomarkers of Autism Spectrum Disorders in Infants with Tuberous Sclerosis Complex (Fixed Costs)  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Early Warning Signs of Impaired Financial Skills in Older Adults  awarded by National Endowment for Financial Education
  • Effect of Pitavastatin on Kidney Function in HIV-infected Persons  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Effectiveness of DiscontinuinG BisphosphonatEs Study (EDGE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
  • Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis  awarded by RHEUMATOLOGY RESEARCH FOUNDATION
  • Epidemiology of Dental Caries and Immunity in Children  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS
  • Examining Patterns and Correlates of Wellness in Persons with Multiple Sclerosis who use Wheelchairs  awarded by CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS
  • Exploring the Effects of Rehabilitation on Brain Remodeling in Progressive MS  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Functional Change in Mild Cognitive Impairment  awarded by National Institute on Aging/NIH/DHHS
  • Glutamate, Brain Connectivity and Duration of Untreated Psychosis  awarded by National Institute of Mental Health/NIH/DHHS
  • Harnessing Neuroplasticity to Promote Rehabilitation: CI Therapy for TBI  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
  • Host Immune Responses to Chlamydia trachomatis Candidate Vaccine Antigens and their Association with Clinical Correlates of Protective Immunity in Women  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Improving Cognition In People With Progressive Multiple Sclerosis: A Multi-Arm, Randomized, Blinded, Sham-Controlled Trial Of Cognitive Rehabilitation And Aerobic Exercise  awarded by MULTIPLE SCLEROSIS SCIENTIFIC RESEARCH FOUNDATION CANADA
  • In Silico Screening of Medications for Slowing Alzheimer's Disease Progression  awarded by National Institute on Aging/NIH/DHHS
  • Innate Immunity and Viral Renal Allograft Injury  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Integrating Novel Mechanisms Controlling Sodium Excretion and Blood Pressure  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Integrating Novel Mechanisms Controlling Sodium Excretion and Blood Pressure - Admin Core  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Investigating the Impact of Cognition on Capacity in Multiple Sclerosis  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/  awarded by University of California, Los Angeles
  • Lipoic Acid for the Treatment of Progressive Multiple Sclerosis  awarded by Oregon Health & Science University
  • Liposomal Recombinant Vaccine and Caries Immunity  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Longitudinal Studies of Coronary Heart Disease Risk Factors in Young Adults (CARDIA) - Coordinating Center  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Modifications to Implement Lupus Decision-Aid Successfully in COVID-19 Era  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE
  • Molecular Basis of Pathogenicity of IgA1-Containing Immune Complexes  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Myasthenia Gravis Patient Registry Work Order #13 Longitudinal Follow-Up  awarded by Myasthenia Gravis Foundation of America, Inc.
  • Myasthenia Gravis Patient Registry Work Order #15  awarded by Myasthenia Gravis Foundation of America, Inc.
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Admin Oversight Component  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Coordinating Center  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • National Resource Center for High-Impact Clinical Trials in Medical Rehabilitation: Pilot Projects Component  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Neurofibromatosis Clinical Consortium Award  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
  • Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson’s Disease  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients  awarded by National Cancer Institute/NIH/DHHS
  • Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients  awarded by BECKMAN RESEARCH INSTITUTE (CITY OF HOPE)
  • Optimization of Saturation Targets and Resuscitation Trial (OptiSTART)  awarded by University of Texas Southwestern Medical Center at Dallas
  • Pilot and Feasibility Trial of a Telehealth Dietary Intervention for MS  awarded by National Multiple Sclerosis Society ^
  • Population Genetics Analysis Program: Immunity to Vaccines/Infections II  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Premature Infants Receiving Milking or Delayed Cord Clamping: Randomized Controlled Multicenter Non-Inferiority Trial (PREMOD2)  awarded by SHARP HEALTHCARE FOUNDATION
  • Preventing Epilepsy using Vigabatrin in Infants with Tuberous Sclerosis Complex  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group
  • Private Grant  awarded by EXELIXIS, INC.
  • Private Grant  awarded by MEDTRONIC, INC.
  • Private Grant  awarded by GW RESEARCH LTD.
  • Private Grant  awarded by GW RESEARCH LTD.
  • Private Grant  awarded by CREALTA PHARMACEUTICALS, LLC - NEW
  • Private Grant  awarded by BOSTON SCIENTIFIC CORPORATION
  • Private Grant  awarded by HORIZON PHARMA USA, INC.
  • Private Grant  awarded by MEREO BIOPHARMA 4 LIMITED
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by ABBVIE INC
  • Project BIPAMS: Behavioral Intervention for Physical Activity in MS  awarded by National Multiple Sclerosis Society ^
  • REduCing Immunogenicity to PegloticasE (RECIPE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
  • Rehabilitating Extremity Use after Multiple Sclerosis  awarded by National Multiple Sclerosis Society ^
  • Rehabilitation Research Resource to Enhance Clinical Trials (REACT)  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Resveratrol and Exercise to Treat Functional Limitations in Late Life  awarded by National Institute on Aging/NIH/DHHS
  • Slow Wave Sleep as a Biomarker of Rehabilitation-Induced Cognitive Improvement in Parkinson's Disease  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • Structural and Neurometabolic White Matter Integrity in the Deficit Syndrome  awarded by National Institute of Mental Health/NIH/DHHS
  • TSC Autism Center of Excellence Research Network (TACERN) Research  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Targeted Clinical Research to Address Select Viral Infections-A Phase II Randomized Six Weeks of Oral Valganciclovir Therapy in CMV Infants with Hearing Loss  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Targeted Clinical Research to Address Select Viral Infections-An Adaptive Pharmacokinetic, Pharmacodynamic, Concentration Response Investigation of CMX-001 in the Infants with Neonatal Herpes (HSV) Followed by Randomized Assessment  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Targeted Clinical Research to Address Select Viral Infections-An Adaptive, Sequential Study Evaluation Prevention of Neonatal Herpes Simplex Virus Disease: Detection of Maternal Herpes Simplex Virus Shedding at Delivery  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Targeted Clinical Research to Address Select Viral Infections-Pharmacokinetic, Pharmacodynamic and Resistance Evaluation of Intravenous Ganciclovir in Premature Infants  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Targeted Clinical Research to Address Select Viral Infections-Safety, Tolerability and Pharmacokinetic Properties of CMX001 in Renal Transplant Recipients with BK Viremia.  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Technique to Enable Return-to-Work by Employees with Long COVID Brain Fog  awarded by Administration for Community Living/DHHS
  • The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS
  • The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical Center  awarded by BALL STATE UNIVERSITY
  • The Exercise and Physical Activity Collaborative Team (ExPACT): a Proposed MoTrPAC Clinical Center  awarded by BALL STATE UNIVERSITY
  • The Exercise and Physical Activity Collaborative Team (ExPact): A Proposed MoTrPAC Clinical Center  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS
  • The UAB STI CRC - Project 3: Effect of Trichomonas and BV on Chlamydia Concordance and Treatment Outcomes  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease - Project One: A Phase IIB Clinical Trial of the Safety and Efficacy of a NOX1/4 Inhibitor in IPF  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • Transferring Speed of Processing Gains to Everyday Cognitive Tasks after Stroke  awarded by National Institute on Aging/NIH/DHHS
  • Treadmill Walking Exercise Training Effects on Cognition and Brain Function in Multiple Sclerosis: A Systematically-Developed Randomized Controlled Trial  awarded by National Institute of Child Health and Human Development/NIH/DHHS
  • UAB Biostatistics Pre-Doctoral Training Program  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS
  • UAB Cannabidiol Program  awarded by ALABAMA DEPARTMENT OF COMMERCE
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for Clinical and Translational Science (CCTS) (3 Linked Awards UL1, KL2, TL1)  awarded by National Center for Advancing Translational Sciences/NIH/DHHS
  • UAB Center for Clinical and Translational Science (CCTS) UL1  awarded by National Center for Advancing Translational Sciences/NIH/DHHS
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research - Admin Core  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research - Administrative Core  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB/UCSD O'Brien Core Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • UAB/UCSD O'Brien Core Center for Acute Kidney Injury Research - Administrative Core  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Unlocking Dystonia from Parkinson's Disease with Directional DBS Technology  awarded by Fox (Michael J.) Foundation for Parkinson's Research
  • Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease.  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • Teaching Activities

  • BST619 - Data Collection Management (Spring Term 2008)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2008)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2009)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2010)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2011)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2012)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2013)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2014)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2016)
  • BST625 - Design/Conduct Clinical Trials (Summer Term 2017)
  • BST690 - Biostatic Consult and App Prob (Summer Term 2010)
  • BST690 - Biostatistical Consulting (Spring Term 2008)
  • BST695 - Special Topics (Fall Term 2014)
  • BST697 - Internship in Biostatistics (Spring Term 2010)
  • BST697 - Internship in Biostatistics (Summer Term 2008)
  • BST698 - Non Thesis Research (Fall Term 2007)
  • BST698 - Non Thesis Research (Fall Term 2010)
  • BST698 - Non Thesis Research (Fall Term 2012)
  • BST698 - Non Thesis Research (Fall Term 2013)
  • BST698 - Non Thesis Research (Fall Term 2015)
  • BST698 - Non Thesis Research (Fall Term 2016)
  • BST698 - Non Thesis Research (Spring Term 2008)
  • BST698 - Non Thesis Research (Spring Term 2010)
  • BST698 - Non Thesis Research (Spring Term 2011)
  • BST698 - Non Thesis Research (Spring Term 2012)
  • BST698 - Non Thesis Research (Spring Term 2013)
  • BST698 - Non Thesis Research (Spring Term 2015)
  • BST698 - Non Thesis Research (Spring Term 2016)
  • BST698 - Non Thesis Research (Spring Term 2017)
  • BST698 - Non Thesis Research (Spring Term 2018)
  • BST698 - Non Thesis Research (Summer Term 2009)
  • BST698 - Non Thesis Research (Summer Term 2010)
  • BST698 - Non Thesis Research (Summer Term 2011)
  • BST698 - Non Thesis Research (Summer Term 2017)
  • BST795 - Advanced Special Topics (Fall Term 2021)
  • BST798 - Non-Dissertation Research (Fall Term 2007)
  • BST798 - Non-Dissertation Research (Fall Term 2008)
  • BST798 - Non-Dissertation Research (Fall Term 2012)
  • BST798 - Non-Dissertation Research (Fall Term 2013)
  • BST798 - Non-Dissertation Research (Fall Term 2014)
  • BST798 - Non-Dissertation Research (Spring Term 2012)
  • BST798 - Non-Dissertation Research (Spring Term 2013)
  • BST798 - Non-Dissertation Research (Spring Term 2014)
  • BST798 - Non-Dissertation Research (Spring Term 2015)
  • BST798 - Non-Dissertation Research (Summer Term 2012)
  • BST798 - Non-Dissertation Research (Summer Term 2013)
  • BST798 - Non-Dissertation Research (Summer Term 2014)
  • BST798 - Non-Dissertation Research (Summer Term 2015)
  • BST799 - Dissertation Research (Fall Term 2007)
  • BST799 - Dissertation Research (Fall Term 2013)
  • BST799 - Dissertation Research (Fall Term 2014)
  • BST799 - Dissertation Research (Fall Term 2015)
  • BST799 - Dissertation Research (Fall Term 2016)
  • BST799 - Dissertation Research (Fall Term 2017)
  • BST799 - Dissertation Research (Spring Term 2008)
  • BST799 - Dissertation Research (Spring Term 2014)
  • BST799 - Dissertation Research (Spring Term 2015)
  • BST799 - Dissertation Research (Spring Term 2016)
  • BST799 - Dissertation Research (Spring Term 2017)
  • BST799 - Dissertation Research (Summer Term 2008)
  • BST799 - Dissertation Research (Summer Term 2014)
  • BST799 - Dissertation Research (Summer Term 2016)
  • BST799 - Dissertation Research (Summer Term 2017)
  • Education And Training

  • Doctor of Philosophy in Biometrics, University of Texas System : Health Science Center-Houston 1974
  • Full Name

  • Gary Cutter